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ABSTRACT
An investigation was undertaken into the effects of the 
anti-1 enkaemic drug Myleran on regenerating rat liver. The 
effects on DMA synthesis and the cell cycle were studied.
Random bred rats were subjected to partial hepatectomy 
and experimental animals given Myleran (i,4-dimethanesulphon— 
oiybutane) in dispersion. Controls were given dispersant 
lacking Myleran and analysed concurrently.
DNA synthesis was followed using radioactive thymidine. 
%e specific activity of the DNA was measured over three days 
following partial hepatectomy. An investigation into ’apparent* 
thymidine kinase activity was undertaken in conjunction with 
the studies on DNA synthesis. Levels of nucleic acids were 
determined.
Regeneration in the weight of the liver remnant after 
partial hepatectomy was followed and a histological examination 
conducted in which the mitotic index and the incidence of mit­
otic abnormality were determined. The lengths of the individual 
mitotic phases and the phases of the cell cycle were found by 
the construction of mitotic labelling curves.
The drug was found to decrease the ability of the 
liver to regenerate and to partially inhibit DNA synthesis.
These results are explained by a decrease in the ’apparent’
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thymidine kinase activity and are discussed. No significant 
effects were found on the ENA or DNA contents of the liver 
remnant. The levels of mitotic abnormalities increased 
following Myleran treatment and were measured for the different 
phases of mitosis. Measurements of mitotic index over the 
first 26hr. following Myleran treatment gave variable results.
The drug was found to shorten the length of mitosis, determined 
by summation of the individual mitotic phases or from the 
graphs of ^  labelled mitoses.
Analysis of the curves of labelled mitotic figures 
was complicated in the case of the Myleran-treated rats by the 
absence of a second wave of labelled mitoses; thus total cell 
cycle time (T^ ) and the length of the phase could not be 
found. However the G^ and S phases of the cell cycle were 
found to be lengthened for Myleran-treated rats; the significance 
of these findings is discussed.
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INTRODUCTION
1 LIVER REGENERATION
1.1 Early Work.
If ve disregard the legend of Prometheus, the 
possibility of the liver to regenerate was first recognised 
by Andral in 1834 (see Milne, 1909)# The first experimental 
production of liver regeneration was carried out in Italy by 
Colucci (I883) who injured guinea pig liver and noted the 
appearance of new hepatocytes. He thought, however, that these 
arose from leucocytes. Canalis (I885), followed by Podwyssozki 
(I886), removed wedges of liver and demonstrated proliferation 
of hepatic cells with the formation of new bile ducts, 
Podwyssozki observed that mitotic figures appeared near the 
wound within 36hr. In 1889 Ponfick (see Looney,I960) 
found that removal of as much as three-quarters of the liver 
of a rabbit still resulted in regeneration. Von Keister in 
I894 (see Looney, I960) was one of the earliest to observe 
that the liver would regenerate after repeated removal of 
tissue. The first major study of the quantitative aspects of 
liver regeneration was that of Higgins & Anderson (193I)#
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1.2 Factors affecting Liver Regeneration.
Normal liver, when subjected to the stimulus of partial 
hepatectomy, comprising removal of the left lateral and median 
lobes (Higgins & Anderson, 193l), undergoes compensatory hyper­
plasia, termed regeneration, of the two residual lobes (Bucher 
et al. 1969)* Liver regeneration is the subject of an extensive 
literature dealing with the biochemical, physiological and 
metabolic activities during restoration to the original size 
(Bucher, I963» Bengmark, 1970).
Various factors influence the restoration of the 
liver following partial hepatectomy and these factors must be 
standardized in studies on liver regeneration.
a) Resection of the left lateral and median lobes leads to 
a reduction of the liver mass by approximately 68^ (Slonaker 
rats: 68.4^ , Brues, Drury & Brues, 193&; Wistar rats: 68.3^ , 
Bucher & Glinos, 1950; Sprague-Dawley rats: 68.3^ , Bucher &
Swaffield, 1964). The regenerative rate is related to the
size of resected liver when either the incorporation of 
thymidine (Mac Donald, Rogers & Pechet, 1962) or increase in 
liver weight (Straube & Patt, I961) are used as the criterion 
of regeneration.
b) The age of the animal influences the liver regeneration
(Bucher & Glinos, 1950). The rise in the mitotic activity is
r 14 ]
delayed with age, as is the incorporation of [2- Cj thymidine
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Into the DNA (Bucher, Swaffield & Ditroia, I964),
c) There is evidence for diurnal variation in the 
deposition of glycogen, synthesis of ENA, DNA and phospho­
lipids, and in the time of mitosis in regenerating rat liver 
(Kelly et al. 1951; Halherg & Barnum, 19&1; Halherg, 196O;
Ddring & Rensing, 1975)*
d) Diet is capable of modifying the proliferative rate
(Soberon & Sanchez-Q., I961)#
e) Sex of the animal appears to have no important effect
on the regenerative process (Bucher, 1963)* Pregnancy however, 
may slightly modify liver regeneration (Gershbein, 1958).
f) Surrounding temperature has a considerable effect on the 
changes in the liver of animals after partial hepatectomy 
(Chevillard, Hamon & Mayer, 1957)* At 26^ , near the temperature 
of minimum heat production for the rat (Herrington, 1940),
the effects of small variations in temperature on the regener­
ation arc minimised.
1.3 Liver Regeneration and the Reticuloendothelial 
System.
Anatomically "the hepatic lobule consists of the tissue 
specific parenchymal cells (60-65^ ).and the smaller endothelial 
cells of the Kuppfer type (30"35/o) which make up part of the 
reticulendothelial system (RES). Changes in this littoral or 
endothelial cell population are unreliable as an index of the 
regeneration after partial hepatectomy, as they constitute only
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a part of the whole hody response.
Animals given chronic pretreatment with endotoxin 
exhibited arrested DNA synthesis in response to regeneration 
(Agarwal, 1973)f while animals given a prior injection of 
Celite, which is known to alter EES function (Agarwal & Berry, 
1966), show enhanced DNA synthesis after resection (Simek et 
al. 1968). Both these results suggest the seeming involvement 
of the RES during the regenerative response.
1.4 Morphological Changes accompanying Regeneration.
Glycogen-free, fat-free vacuoles appear 5min after 
partial hepatectomy - they may be lysosomes (Aterman, 1952).
In electron microscopy numerous fat droplets appear in the 
cytoplasm Ihr. after partial hepatectomy (Jordan, 1964) and 
osmophilic bodies are decreased proportionally.
From 30min to Shr. after hepatectomy, basophilic bodies 
(RNA-protein complexes, Lagerstedt, 1953) start to disperse, 
first peripherally, then spreading centrally (Glinos, 1958). 
This is reflected in a disaggregation of the endoplasmic 
reticulum. ’Cloudy swelling’ appears in some of the mitochon­
dria (Bernhard, 1958).
Within 6hr. of partial hepatectomy one finds cytoplas­
mic inclusions, described as vacuoles by Aterman (1961) or
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hyalin protein droplets hy Weinhren (l959)f within the liver. 
The glycogen content becomes very low by lOhr. and remains low 
for several days following partial hepatectony (Harkness, 1957) 
By 12hr. there is an increase in the size of the cells, nuclei 
and nucleoli,which-is maximal at 24hr. (Harkness, 1957» 
Weinhren, 1959) or 36hr, (Ekelund, 197l)# Nucleoli are 
increased in number (St. Mironescu & Dragomir, 1966), At l6— 
18hr, following partial hepatectomy the endoplasmic reticulum, 
in contact with groups of mitochondria, starts to reform; 
first centrally then peripherally (Bernhard & Rouiller,1956; 
Glinos, 1958). Normal structure is restored by 36-48hr. 
(Bernhard, 1958; Oberling, 1959).
1.4.1 Microbodies
According to Mochizuki & Tsukada (l970)* the number of 
microbodies of regenerating rat liver cells per unit area of 
cytoplasm is decreased 1 day after partial hepatectomy and 
then increases gradually up to 14 days following the operation. 
Rouiller & Bernhard (1956) state that at 36hr. microbodies 
are larger, more abundant, polymorphic and more organised 
internally. They may be precursors of mitochondria or lysos­
omes (Rouiller, I960).
1.4.2 Mitotic Activity
Mitotic activity follows DNA synthesis by 6—81ir.
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(i.e. with a peak at 26-32hr.) and proliferation spreads 
inwards towards the central vein (Grisham, I960). Mitotic 
figures appear to have a peak at 28hr. according to Cater et 
al. (1957) and Weinhren (l959)t though Shima & Asashima (l97l) 
placed the peak at 36hr.
1.4.3 Nuclearity and Ploidy
It is the diploid mononuclear cells that proliferate 
most actively (Uryvaeva & Marshak, I969)* Following mitosis 
the proportion of hinuclear cells falls from 25-30^ (Harrison, 
1953) to 8-10^ (st. Aubin & Bucher, 1952). The number of 
parenchymal nuclei is not restored to normal, though DNA is 
restored (Harkness, 1957) reflecting the increase in ploidy.
Diploid and tetraploid nuclei passing through the DNA 
synthetic (s) phase are labelled by^E^ thymidine while 
octaploid nuclei are unlabelled (Uryvaeva & Marshak, 1969)# 
70—80^ of normal adult parenchymal nuclei are tetraploid and 
1-2^  ^octaploid. \fhen regeneration is completed the proportion 
of tetraploid and octaploid nuclei has increased by 10^ and 
505« respectively (Post et al. I96O). The increased ploidy 
persists indefinitely (Himes et al. 1957)#
1.5 Biochemical Changes accompanying Regeneration.
Morphological considerations suggest that any analyses
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relating to cytoplasmic constituents will give values 
approximating to the composition of parenchymal cells, while 
those relating to nuclear constituents will reflect a composite 
of cell types.
1.5*1 Carbohydrate
The liver is the principal store of glycogen. During 
regeneration glycogen is mobilised with consequent decrease 
in liver glycogen content (Harkness, 1957)* The blood glucose 
level is maintained and gluconeogenesis (the formation of 
glucose from non-carbohydrate sources) is increased (Camargo 
& Migliorni, 197l)*
1.5*2 Lipid
The liver is a site of fat synthesis and the principal 
site of fatty acid oxidation. The principal site of biosynth­
etic functions associated with lipid is the microsomal fraction 
(Abraham et al. I961).
There is a change in the relative proportions of the 
unsaturated fatty acids during the first 3 days (Johnson et 
al. 1954) and other lipids, mainly neutral fats, accumulate 
during the first few hours (Harkness, 1957)* These lipids are 
derived from fat deposits rather than by in situ synthesis
since :
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&) if fat mobilisation is depressed by adrenalectomy, 
fatty infiltration does not occur (Brody et al. I961);
b) synthesis of fatty acids from acetate remains
low for the first few days of regeneration (Johnson & Albert,
i960).
In glucose-injected, partially hepatectomized rats 
the mean increase in total lipid is only 50^  of non-injected, 
partially hepatectomized animals (Bengmark, Olsson & Svanborg, 
1965)> this is presumably due to the stimulation of glucose 
oxidation both diminishing the release of depot free fatty 
acid (Dole, 1956) and lessening uptake of plasma free fatty 
acids (Spitzer & Me Elroy, I960). This is consistent with 
the post-hepatectoray increase of plasma free fatty acid found 
by Fex & Olivecrona (1968)» Camargo, Cornicelli & Cardoso 
(1966), on the other hand, found no significant differences in 
levels of free fatty acid in 70^ hepatectomized rats and sham- 
-operated controls in the first 24hr. after operation.
At 18hr. the triglyceride content, the rate of 
estérification of fatty acids to triglycerides and phospho­
lipids (determined by incorporation of [ ^ c^j glycerol) are all 
elevated. Formation of compound lipids, such as inositol 
phosphatide and sphingomyelin (estimated by use of ^^^c] 
acetate), are also increased. The peak values in phosphatidyl- 
serine,phosphatidylethanolamine and phosphatidylcholine content 
however, occur later (Johnson & Albert, I960). These results
-  21 -
32agree with studies on the incorporation of P into phospho­
lipids. There is a linear increase in total phospholipid 
during the first 48hr. after operation, though little change
in the relative concentrations of individual phospholipids.
32There is an increase of incorporation of P into the 
phosphatidylserine and phosphatidylinositol fractions, though 
a lowered incorporation into phosphatidyl choline, in compar­
ison with control unoperated rats (Fex, 1970).
1.5.3 Amino Acids
Six hours after operation there is a fall in hepatic 
glutamine and a rise in glutamate, aspartate end lysine. The 
latter three amino acids start to fall at 20-30hr. as other 
amino acids start to increase (Ferrari & Harkness, 1954).
1.5.4 Protein
Hates of protein synthesis are generally determined 
either in vivo using labelled amino acids, or in vitro using 
the microsomal fraction plus soluble fraction, labelled amino 
acid, an energy source and co-enzymes. In vivo studies are 
complicated hy alterations of precursor pool size, penetration 
of precursors and differing turnover rates of different 
proteins, while in vitro studies measure only the activity of 
an isolated part of the system.
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Net increment of protein is not easily detectable 
until nearly 12hr.; maximal protein synthesis has been found 
between 36 and 48hr, (Harkness, 1957 and Campbell, 1958, give 
reviews: see also Schreiber et al. I971)# Busanny-Caspari & 
Beimel (1963) found that initially liver protein content lagged 
behind, then increased linearly with, the weight of regenerated 
liver.
The mechanism of the increase in protein synthesis is, 
according to Van Lancker (1969) likely to result from 
increased synthesis of messenger and ribosomal ENA, rather 
than from an increase in their activity. Earl & Bindley (l97l) 
propose the intracellular concentrations of amino acids or 
aminoacyl-tliNAs as rate limiting. Liew & Gornall (l973) 
suggest the acétylation of ribosomal proteins to be closely 
associated with the regulation of protein synthesis during 
regeneration.
Microsomes appear to be the site of protein synthesis 
in regenerating liver, since they incorporate labelled amino 
acids most rapidly in a cell-free system (Hoagland, I961).
1.5.5 Histone
The nuclear histones have a synthetic peak at 26hr. 
with a lower peak at 56hr. In contrast, cytoplasmic proteins 
synthesize maximally at 56hr. with a smaller peak at 26hr.
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(Evans, Holbrook & Irvin, I962). Invthe regenerating liver of 
rat and mouse, nucleochromosomal protein synthesis resembles 
(in rate / time) DNA. synthesis but precedes it by 4-12hr.
(Savina & Rdvich, 197%)#
1.6 Enzymes.
1.6.1 General Enzyme changes after Partial Hepatectomy
According to Bengmark*s review (l9?0), it appears that 
there is a decrease in activity of nearly all the enzymes in 
the early post—operative phase. Cytochrome oxidase (EC 1.9*3#l), 
acid phosphatase (EC 3*l*3*2)and glucose-6-phosphatase 
(EC 3*1*3.9), representative of the mitochondria, lysosomes 
and microsomes respectively, did not differ in their rates of 
restitution when studied over ?2hr. after partial hepatectomy. 
These enzymes were restored in direct proportion to the total 
protein (Van Lancker & Sempoux, 1958). However, the subcellular 
fractions and enzymes of particular subcellular fractions often 
differ in their rates of restitution. Alterations in enzymes 
of microsomal and soluble cell components in general precede 
those in mitochondria (Harkness, 1957)*
1.6.2 Microsomal Fraction
This fraction may be defined (Roodyn, 19^ 7) as 
consisting of a mixture of ribosomes and elements of endoplasmic
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reticulum. According to Reid (196?)* microsomal enzymes 
are generally located in the membranes rather than in the 
ribosomes. Microsomal activities were increased in regenerating 
liver (Valkinshaw & Van Lancker, 1964). Amylase, found in the 
microsomal fraction (Bresemer & Rutter, I961), increases in 
activity markedly in the first phase of regeneration 
(Albertini et al. I966). The activity of acid phosphatase 
(eC 3*1*3«2) increases 18hr. after partial hepatectony 
(Walkinshaw & van Lancker, 1964). The activity of glucuron­
idase (eC 3*2.1.31), 37-409^  of which is in the microsomal 
fraction (Walker, 1952), starts to increase at 24hr. following 
partial hepatectomy (Walkinshaw & van Lancker, 1964; Ekelund, 
1971)» although a contrasting view is given by Albertini et 
al. (1966). Alkaline phosphatase (EC 3*T*3*l) which is 42% 
microsomal (Allard et al. 1952), increases markedly in activity 
after partial hepatectomy and there is also a progressive 
increase in its activity from the central lobular vein towards 
the periphery of the lobule (Tsuboi et al. 1954; Palma & 
Dominedo, I963).
Regeneration has little effect on the specific 
activities of such microsomal enzymes as glucose-6-phosphatase, 
NADH and reduced NADPII, dehydrogenases (EC 1.6.99*3 and 
1.6.99.2) and lipoamide dehydrogenase (EC 1.6.4.3) (protein 
disulphide reductase (EC 1.6.4.4)), while the capacity to 
perform certain oxidative déméthylations and to bind carcino­
genic amines falls rapidly after a lag of 12-l4hr.
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Cytochrome content is rednced by $0$^  at this time (Von 
der Decken & Hultin, I960)#
Microsomal drng-metabolizing enzymes are not affected 
to the same extent by regeneration (Fonts et al. I961), though 
there is a generalized fall in their activities (Fonts, I963).
1.6.3 Mitochondrial Fraction
The number of mitochondria is depressed during the 
first week of regeneration (Allard et al. 1952), although 
according to Gear (1965) partial hepatectomy induces a massive 
biogenesis of mitochondria. In normal liver mitochondria 
may turn over as complete functional units (Fletcher & Sanadi, 
1961), but not all mitochondrial enzymes change at parallel 
rates during regeneration. This implies that, like the 
microsomes, these organelles are renewed in modified form 
(Gear, 19?0)* The specific activity of marker enzymes for 
matrix, inner membrane and inter-^ nembrane remain constant or 
are altered synchronously. In contrast the specific activities 
of monoamine oxidase (EC 1.4.3.4) and kynurenine 3-hydroxylase 
(eg 1.14.1.2), both outer membrane markers, fall by 6/^ and 
40^ , respectively, from their control values 4 days after 
operation, and normalize after 3 weeks. The inner membrane 
and matrix seem to turn over as a unit, while the enzymes of 
inner and outer membranes are synthesized asynchronously 
(Gear, 1970).
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Recent work (Ekelund,1971) on succinic dehydro­
genase (eC 1,3.99.1) suggests that its activity increases 
following partial hepatectomy, In contrast to the earlier work 
of Pearson, Grove & Green (l959).
In contradiction to earlier observations (Wilczok,196l), 
the amounts of aspartate aminotransferase (EC 2,6.1,1) and 
alanine aminotransferase (EC 2.6.1.2) have been shown to 
increase with the proliferative rate; an increase in the 
content of transminases 24hr. following partial hepatectomy, 
followed by a decrease at 24hr., has been reported (Sheid,
Morris & Roth, I963; Bengmark, Ekholm & Olsson, 196?»
Nikiforov & Larionova, 19?l).
1.6.4 Nuclei
Nuclear glycolytic activity is increased, becoming maximal 
12hr. after operation (Siebert et al. I961), though aldolase 
(EC 4.1.2.7) activity is decreased (Albertini et al. 1966). 
Stirpe & Aldridge (196I) have claimed that isolated nuclei 
synthesize NAD in decreasing amounts for 3 days after operation • 
an indication of decreased NiD pyrophosphorylase (EC 2,7.7.1) 
activity. This has been questioned by Ferris & Clark (l97l), 
who have found that this enzyme and NMN pyrophosphorylase,
(EC 2.4,2.12) remain at, or slightly above, the initial value 
for 121ir,, then rise continuously till 48hr. after partial 
hepatectomy.
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1.6.5 Other Fractions
In the phagolysosomes proteinase activity increases 
during the first 6hr. then falls till 60hr, Dipeptidase 
activity decreases, followed hy a sharp rise at 48hr.(Hassan, 
Nardelli & Autori, 1962).
The number of microbodies per unit area of cytoplasm 
in regenerating liver cells decreases 1 day after partial 
hepatectomy then increases up to the 14th day in rats.
The activity of catalase (EC 1.11.1.6) was proportional 
to the numerical change in microbodies (Kochizuki & Tsukada, 
1970)* The net rate of albumin synthesis in the ribosomes 
changes only slightly (Schreiber et al. 1971).
1.6.6 Enzymic Routes of DNA and BNA Synthesis
Reviews of nucleic acid enzymic routes are to be found 
in Bucher (1963) and Murray (l97l)# A composite diagram 
based on the above sources is shown in Fig. 1. The abbreviat­
ions and symbols used are those recommended'in the Journal of 
Biological Chemistry and include:
PRPP <x-5-phosphoribosyl pyrophosphate
OMP orotidylic monophosphate
A,G,C,U,T adenine, guanine, cytosine, uracil,
thymine
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AMP, GMP, IMP, CMP, IMP
ADP etc.
ATP etc.
T
TdR
dTMP, dHMP, etc.
dTDP etc.
dTTP etc.
RNA
DNA
5*-phosphate of rihoayl adenine, 
guanine, inosine, cytosine and 
uridine.
5  ^(pyro)-diphosphate of adenosine, 
etc.
5* (pyro)-triphosphate of adenosine,
etc.
thymine
thymidine
5’-phosphate of 2*-deoxyrihosyl 
thymine, 2*-deoxyrihosyl-5-hydroxy— 
methyl cytosine, etc.
5* (pyro)-diphosphate of 2*—deoxy- 
thymidine etc.
5* (pyro)-triphosphate of 2*-deoxy- 
thymidine etc. 
ribonucleic acid 
deoxyribonucleic acid
The numbers on the diagram indicate enzyme reactions.
Degradation path for uracil. 
Degradation path for thymine. 
Thymidine phosphorylase (EC 2*4.2.4), 
Excretion of deoxycytidine. 
Deoxycytidylate deaminase.
Thymidylate synthetase (EC 2.1.1.b).
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7a Thymidine kinase (EC 2.7.1.21).
7hc Thymidylate kinase.
8 Deoxycytidylate kinase (EC 2.7.4.5).
9 Deoxyadenylate kinase.
10 Deoxyguanylate kinase,
llah Cytidylate kinase.
12ah Adenylate kinase (EC 2.7*4.3)•
13ah Gnanylate kinase (EC 2.7.4,8).
14 DNA polymerase (EC 2,7*7#7).
15 ENA polymerase (EC 2.7.7.6).
16 Enzymes of de novo purine biosynthesis.
17 Adenine phosphoribosyltransferase (EC 2,4,2.7).
18 PEPP amidotransferase (EC 2.4.2.14).
The main pathways for the introduction of pyrimidine 
bases are at the nucleotide level beyond orotic acid and do 
not normally include the free bases or nucleosides, except as 
a means for ’salvage* of degradation products (Komberg, I960), 
Thymidine is on the salvage pathway . Liver is probably the 
major source of purine available for salvage since it contains 
a high activity of PEPP amidotransferase (Casky, Ashton &' 
Vyngaarden, 1964). Indirect evidence for significant purine 
salvage following partial hepatectomy is that the activities 
of adenine and hypoxanthine/guanine phosphoribosyltransferase 
are augmented following the operation (Murray,1966),
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1.6.7 Engjymes Fluctuating with DNA level and Hiatone 
Phosphorylation
The earliest enzyme observed to change in activity after 
partial hepatectomy is ornithine decarboxylase (EC 4.1.1.17) 
(ihissell, Medina & Snyder, 1970). The activity of this enzyme 
increases in parallel with the increase in DNA and BNA content, 
and proceeds the peak of DNA synthesis. The enzyme catalyses 
the formation of putrescine whose production is rate-limiting 
for the production of spermine. Spermine is essential for the 
assembly of increased numbers of polysomes after partial 
hepatectomy (Ord & Stocken, 1972).
The activities of NAD pyrophosphorylase (EC 2,7.7«l) 
and NMN pyrophosphorylase (EC 2.4.2.12) rise continually from 
12hr. till 48hr. after operation (Ferris & Clark, 197l)# There 
is positive correlation between DNA synthesis and NAD 
pyrophosphorylase activity (Haines et al. 1969)#
The acidic proteins of chromatin are generally assumed 
to be specific regulators of gene activity, and histones to 
preserve nucleoprotein structure. Only the content of histone 
F2 shows a close correlation with the increased DNA content 
between 15hr. and 26.5hr. following partial hepatectomy (Evans, 
Holbrook & Irvin, I962). According to Revich, Savina &
Bokhon'ko (l97l), the maximum rate of synthesis of both FI and 
F2b fractions occurs l6-18hr. after partial hepatectomy. Sung,
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Diion & Smithies (l97l) found that l^ hr. after partial hepatec­
tomy only the 2b histone was phosphorylated. They regarded 
this as a possible specific control event. Histone FI phospho- 
kinase activity increases in the S period (Siebert, Ord & 
Stocken, 197l)* Gutierrez-Cernosek & Hnilica (l97l) measured 
synthesis of histones during liver regeneration using [^^c] 
lysine. They found that the peak of incorporation proceeds the 
peak of DNA replication. At the tiiae of maximum DNA synthesis, 
arginine-rich F3 and lysine-rich FI histones incorporate lysine 
several times more rapidly than F2a and F2b histones. There 
is intensive phosphorylation of F2b, FI and F2a during the first 
6hr, where the content of F3 histone does not increase.
However, during the period of intensive DNA replication all 
the histones are phosphorylated in proportion to their rates 
of synthesis.
1.6.8 Enzymes involved in Purine and Pyrimidine Base Synthesis
Partial hepatectomy causes an increase in the flow of 
metabolites into the pyrimidine path in the early stages of 
liver regeneration (Fausto, 1972). Various enzymes associated 
with pyrimidine synthesis,such as carbamoylphosphate synthetase 
(eC 2.7.2.5), aspartate transcarbamylase (EC 2.1.3.2), dihydro— 
orotase (EC 3*5*2.3)« dihydro-orotate dehydrogenase (EC 1.3.3*l) 
and uridine kinase (EC 2.7.1.48), increase in specific activity 
12-24hr. after partial hepatectomy (Bresnick, 1965)* Fig* 1 
shows pyrimidine interconversions in detail, enzyme alterations
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during regeneration are geared to producing thymidine triphos­
phates,
Dihydro-uracil dehydrogenase (EC 1,3*1.l), the rate 
limiting enzyme in the degradation of Ü or T, falls in regen­
erating liver to 74^ of sham—operated controls at 24hr, after 
partial hepatectomy (Sherry, Morris & Weher, 197l)# According 
to Fritzson (1964) this is due to a 24hr, delay in the 
synthesis of the enzyme from the initiation of liver growth, 
Stevens & Stocken (1963) showed that there is a correlation 
between activity of thymidine phosphorylase and DNA synthesis 
in regeneration.
One may compare the two major paths for biosynthesis 
of thymidine nucleotides;
1 UMP -> dUMP -> dTMP
2 UMP -> CMP dCMP dUMP -> dTMP
Crone & Itzhaki (1963) concluded from orotate studies,
using the technique of flooding with unlabelled cytidine, that 
dTMP is formed to the greatest extent by route 1, Deoxycytid­
ylate deaminase (converting dCMP —^ dUMP) activity increases 
eight—fold 2 days after partial hepatectomy (Oda, Holtzer & 
Chiga, 1966). The specific activity of thymidylate sjmthetase 
(converting dUMP —> dTMP) is barely detectable in normal 
liver but increases 4—10 fold in regenerating liver (Hartmann
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& Heidelberger, I961),
The activity of thymidine kinase has heen reported to 
he very low in preparations of adult liver, though higher in 
foetal (Klemperer & Haynes, I968) and regenerating liver 
(Bucher, 1963)# According to Bianchi, Crathorn & Shooter (1962) 
thymidine kinase is present during the early stages of regener­
ation in rat liver. Activities of hoth thymidine and 
thymidylate kinases increase from 18-30hr. in regenerating 
rat liver (Ol’shanetskaya, Kavelina & Novikova, 1968; Beltz, 
1962), that of thymidine kinase increasing to six times normal 
control values at 24.5hr, after partial hepatectomy, Mal’Kova 
et al, (1968) found that the activity of thymidine and 
thymidylate kinases of regenerating liver in the rat varied 
directly with mitotic activity,
1.6.9 BNA
53hr. after partial hepatectomy uridine and deoxyuridine 
phosphorylases, which control the production of ENA, increase 
in activity (Yamada, 1962), Both nuclear and nucleolar ENA 
polymerase rise quickly after 70^  partial hepatectomy, apparently 
from de novo synthesis (Ro & Busch, 196?),
Suppression of the increase in the rate of ENA formation 
after partial hepatectomy results in delay in the appearance 
of DNA synthesis (Tsukada, I969).
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1.6.10 DNA.
DNA synthesis increases with DNA polymerase activity 
and this in turn is essentially synchronous to thymidine 
incorporation in rat liver (Ove, Jenkins & Laszlo, 1969» Kizer 
& Howell, 1973).
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2 THE CELL CYCLE
Quastler & Shex*man (l959) first estimated parameters 
of the cell cycle. Both cell cycle and mitotic times may he 
estimated hy use of thymidine and autoradiography (Post
et al, 1963). The generative cycle may he compartmentalised 
into the four phases S (DNA synthetic phase), G^ , and 
M (mitosis) (Lajtha, Oliver & Ellis, 1954), A history of cell 
cycle analysis is given hy Petersen, Tohey & Anderson (I969)#
Biochemical parameters of the cell cycle have heen 
reviewed hy Mueller (l97l); Mitchison (l9^ 9) has reviewed phase 
’markers* in the cell cycle. Additional phase markers, in He 
La cells, (Marks, Paik & Boron, 1973) are commencement of FI 
histone phosphorylation during S phase, and the physiochemical 
characteristics of ornithine — transaminase, which differ in 
G^ , S and G^  (Volpe & Eremenko, 197l)#
Actinomycin (an inhibitor of ENA synthesis) and 
puromycin (an inhibitor of protein synthesis) have heen widely 
used in cell cycle analysis. It is generally agreed from study 
of a number of systems with these inhibitors that the BNA which 
is required for mitosis is synthesised during G^  and S (Crippa, 
1966; Honesi, Molinaro & Siracusa, I969), while the proteins 
required for mitosis are synthesised during G^  (Petersen,
Tohey & Anderson, 19^ 9; Messer, 1973)* Both the ENA and 
protein, synthesised consecutively in the G^  phase, are
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prerequisite for cells to proceed into the S phase 
(Yamada & Hanaoka, 1973) #
There appear to he genetic inducers and repressors 
synthesised during the cell cycle: extracts of liver cells
which are in the phase inhibit DNA synthesis in cultured 
cells (Aujard, Chany & Frayssinet, 1973)» and cells in DNA 
synthesis are capable of stimulating cells in the G^  phase 
into the S phase (Dewey, Miller & Nagasawa, 1973)*
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3 THE ALKYLATING COMPOUNDS ACTIVE IN THE 
TREATMENT OF CANCER
The alkylating agents used in the treaianent of cancer 
have been reviewed by a number of authors (Ross, 1962; tfheeler, 
1967; Haddow, 1973)# Those alkylating agents that have 
extensive biological activity have at least two alkylating groups 
in each molecule. The monofunctional 6—diazo-5-oxo-norleucine 
(don) active biologically, reacts by a bimolecular mechanism, 
while the other alkylating agents react by SN^ or SN^ mechanisms 
(Ross, 1962),
Alkylating agents may be classified according to the 
blood response pattern following their administration. The 
’Myleran type* drugs affect markedly the neutrophil and platelet 
counts, while the lymphocyte count is affected to a lesser 
extent. In contrast the ’nitrogen mustard type* of drugs, 
typified by chlorambucil ((di-2 chloroethylamino) phenylbutyric 
acid) bring about characteristic changes in neutrophil, platelet 
and lymphocyte counts (Dunn & Elson, 19?0), In their effects 
on blood counts, chlorambucil and Myleran each partly mimic 
the effects of radiation. Only in the response of the platelets 
is Myleran truly radiomimetic; a rapid fall in platelet concen­
tration occurs 6-8 days after a single dose, followed by a 
steady rise. It is the lymphocytes that are most affected by 
a single dose of chlorambucil in an analogous fashion to whole 
body x-irradiation (Elson, I963).
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The primary site of action of monofunctional and 
difunctional alkylating agents has heen considered to he the 
mitotic apparatus (Brookes & Lawley, I963; Roller, I969).
There is considerable evidence that DNA. is alkylated both 
in vivo and in vitro (Trams, Nadkarni & Smith, I96I5 Ross,
1962; Brookes & Lawley, 1963» Lawley & Brookes, 1965} Tomisek 
& Simpson, I966), Bifunctional agents, such as the N-mustards, 
the diepoxides or the polyimines may cross-link the guanine 
and thymine bases in DNA, The most extensive alkylation occurs 
on N—7 of guanine (Lawley & Brookes, 1963a) and causes labil- 
isation of the glycosidic link between base and deoxyribose 
and consequent depurination (Ross, 1962), This depurination may:
a) stop replication at this point,
b) cause *skipping* of this unit,
c) introduce nonspecifically any available deoxynucleotide 
(Lawley & Brookes, 1963b),
d) labilise the deoxyribose-phosphate linkage, causing 
chain scission (Ross, I962).
A study by Rhaese & Boetker (l973) of the molecular basis for 
the biological effects of alkylation using transforming DNA has 
indicated that base alkylations are mutagenic and depurination 
or triester breaks are lethal DNA alterations,
Brookes & Lawley (1965) conclude that cross linking of 
DNA is the main cytotoxic action of bifunctional alkylating 
agents. Using ’mustard gas* (2—dichloroethyl sulphide)
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Brookes & Lawley (1963) detected bis (guanin-7-yl) derivatives 
in mouse ascites cells after in vivo treatment which they 
considered evidence for cross-linkage. Other workers using 
bifunctional agents such as the nitrogen mustards have also 
found evidence of cross-linkage (Butman, Chun & Jones, 19^ 9}
Verly & Brakier, 1970)# bheeler (I967) in a review and De 
Cosse & Gelfant (l970), using N-mustard on the Ehrlich ascites 
tumour, have both stressed the probability and importance of 
random cross linkages between DNA, ENA and protein. However 
that there is a disparity between the low alkylation of DNA 
by the alkylating agents and their large amount of cell damage 
is well documented (Biesele, 1963} /^heeler, 1967» De Cosse 
& Gelfant, 1970),
The multiplicity of the possible reactions of 
alkylating agents with biological materials makes it difficult 
to designate any single reaction as the cause of cytotoxicity,
A mechanism of action involving attack at many sites, some 
probably of enzymic nature, rather than direct chemical action 
on the mitotic apparatus (thought to be affected only indirectly), 
is favoured by some authors (De Cosse & Gelfant, 1970)*
There are conflicting reports concerning the phase(s) 
in the cell cycle at which the alkylating agents act (De Cosse 
& Gelfant, 1970; Wheeler, I967). Wheeler (1967) and Lawley & 
Brookes (1963a) suggest that bifunctional alkylating agents 
affect DNA replication by forming interstrand cross-links
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during the S period of the cell cycle; cells would then be 
held up in the phase when strand separation is futilely 
initiated as a prelude to mitosis. An alternative view has, 
however, been presented (Levis, Daniel! & Piccinni, 1965)* 
Verly & Brakier (l970) point out that if DI^A. interstrand cross- 
linkage is the main cause of cytotoxicity of the alkylating 
agents then the duration of the cell cycle is a crucial factor 
in the formation of the cross-links,
3*1 Myleran.
The dimethanesulphonyloxyalkanes have the general
formula:
0 0 
CHj-S-O-(CHg)^ -0-S-CH^
Myleran or Busulphan is the member in which n=4 and is the 
most potent biologically, based on neutrophil depression 
(Elson, 1958).
3.1.1 The Reactions of Myleran with DNA and related Cell 
Constituents
Myleran alkylated guanine in mouse L cells (Mitchell 
& Walker, 1972) though there was no evidence of cross linkage 
found on alkaline dénaturation and renaturation of the DNA.
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Lawley & Brookes (1963a) and Verly & Brakier (1969) both 
conclude that Myleran presents all the features of a monofunc- 
tional alkylating agent, and the latter authors attribute its 
effects to depurination and single strand breakage. Brookes 
& Lawley (1965) showed tliat Myleran was capable of binding 
not only to DNA. but also to ENA. and protein of the liver. 
Bergel’son (l97l) showed that Myleran also interacts with lipid 
in regenerating liver. Myleran’s injury to the mitotic 
apparatus, especially the chromosomes (Roller, 1969), could, 
however, be due to an indirect effect on the lysosomes 
(Allison & Paton, 1969; Davies, Lloyd & Beck, 197l)*
Trams, Nadkarni & Smith (1961) found stimulation of 
the incorporation of orotic acid into the DNA and ENA of 
leukaemic cells by Myleran and inhibition of incorporation of 
labelled P, adenine, formaldehyde and aspartate. Myleran 
increases the incorporation of [^h] thymidine in vitro in 
bone marrow (Niskanen, 1967a,b), but not into seminiferous epith­
elium (Kramer & De Eooij, 1970).
3.1.2 The reaction of Myleran with Protein
Roberts & Warwick (l959a) suggest that Busulphan may 
conjugate to SH groups of proteins to give :
f H  COOH
NH^
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based on analogy with ethyl methane sulphonate (CH^ CH^ OSO^ CH^ , 
*half-Myleran»| Roberts & Warwick, 1958). They suggest 
reaction with cysteine containing compounds and indeed Butler 
& Crathorn (l958) have shown that Myleran and protein (of 
nucleoprotein ) combine. The positively charged sulphonium 
ion may itself modify the function of the protein or it may 
be dethiolated to an alanyl or serine unit (Roberts & Warwick, 
1959a,b; : Parham & Wilbur, 1959) as below:
1
CO
m
co"
NH
I
rCUCHgSH
Cysteinyl unit 
in protein
cncEgStO
I
Ç0
co^
m
I
Sulphonium 
ion product
CnCH^OH
Either
serine
moiety
moiety
Danjic (19^ 6) found that cysteamine and cystamine 
reduced the lethal action of Myleran in the rat. However, the 
hypothesis that the cytotoxicity of Myleran is mediated by thiol 
group alkylation is not supported by Addison & Berenbaum (l97l), 
who found that sub—cutaneous injection of cysteine—HCl 
potentiated the action of Myleran, Shamrai (19^ 9) found that 
Myleran decreased the incorporation of methionine
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in the proteins of liver nuclei and mitochondria,
3.1.3 The Viability of Myleran in the Body
As regards the ’viability* of Busulphan it has a half- 
life of ll-12hr. both in vitro and in vivo (Fox et al. I960). 
Myleran suffers little simple hydrolysis in vivo (Roberts & 
Warwick, 1957) • It reacts by an SN^ type reaction eind its 
rate of reaction will.depend upon the concentration of 
alkylatable centres (Ross, I962).
3.1.4 The Clinical use of Myleran
The clinical use of Myleran was first described by 
Galton (1953). A review of the treatment of chronic myelogenous 
leukaemia by Myleran has been made by Galton (1956), its use 
in this disease being due to its selectivity of action on 
haemopoictic tissues (Elson, I963). A review and interpretation 
of old and new data on the treatment of chronic myelogenous 
leukaemia has been made by Mueller (I963). Kaung et al. (l97l) 
give more recent data on cases of chronic myelocytic leukaemia 
treated with Myleran therapy. The kinetics and cytodynamics 
of the proliferation of leukaemic cells and possible drug 
implications have been reviewed by Doermer (l973) ^nd 
Fernandez—Ranada et al. (l972). It should be noted that the 
continued administration of Myleran in high doses causes 
neoplastic growth in normal liver (Kandori & Kurimoto, I960).
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5.1.5 The effect of Myleran on the Cell Cycle
The effect of Myleran on the cell cycle in vitro has 
heen reviewed (Metcalf, 1973)» and Nagao (l97l) reviews the 
cell cycle and chemotherapy of infantile leukaemic cells. It 
has heen proposed (Elson, 1958a,h) that the phase of the 
cell cycle shows the greatest response to the ’Myleran type* 
drugs. Grimes, Sallman & Frichette (l9&4) substantiated this 
in rat lens epithelium, concluding that Myleran acts in the 
G^  phase in a manner that allows cells to initiate and complete 
DNA synthesis normally but prevents their subsequent mitotic 
division.
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materials
All reagents used were of ’Analar* grade. The standard 
used for DNA assays was calf thymus sodium deoxyribonucleic 
acid (B.D.H. Chemicals Ltd., Poole, England). Solutions to 
be injected were sterilized following Millipore filtration 
(Millipore (U.K.) Ltd., London, England; 3^M pore size).
4.1 Animals.
Hus norvégiens — Hooded Lister strain, male, random 
bred (Animal Suppliers (London) Ltd., Welwyn, England).
Battus rattus — male, random bred (Anatomy Institute, 
Medical University of Debrecen, Debrecen, Hungary).
4.2 Instruments.
Beckman DB 1402 spectophotoraeter (Beckman Instruments 
Ltd., Glenrothes, Scotland).
Packard Tri-Carb liquid scintillation counter (Packard 
Instruments Co. Inc., Downers Grove, 111., U.S.A.).
Microtomes: Beck rotary (Beck, London) and M.S.E. sle­
dge (M.S.E,,London).
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4.3 Hepatectomy and Injections.
Diethyl Ether; Ether Anaesthetic B.P. (May and Baker 
Ltd., Dagenham, England).
Rat Feed: Oioid 41B Breeders Diet (Oxoid, London, 
England). Dextrose monohydrate B.P.
Ifyleran (Busulphan), 1,4—dimethyl sulphonyloxybutane, 
was kindly donated by Dr. D.M. Taylor, Institute of Cancer 
Research, Sutton, Surrey, England,
Dimethyl sulphoxide (B.D.H. Chemicals Ltd., Poole, 
England).
Arachis oil (E.F. Langdale Ltd., New Addington, 
England)•
[^ 6-^ h ] thymidine. ImCi per ml of specific activity 
20-30 mCi mmol""^  in sterilized aqueous solution (Radiochemical 
Centre, Araersham, England).
4.4 Thymidine Kinase Estimations.
pH^cj thymidine. ImCi per ml, specific activity 
15-30 mCi mmol*"^  in sterilized aqueous solution (Radiochemical 
Centre, Amersham, England).
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ATP (sigma Chemical Company, Kingston-upon-Thames, 
England).
Diethylaminoethyl (DEAE) substituted paper circles 
(Whatman DE-81, Maidstone, England).
4.5 Liquid Scintillation.
Silica gel coarse (B.D.H. Chemicals Ltd., Poole, 
England).
Triton X-100 (iso-Octylphenoiypolyethoxyethanol 
containing approximately 10 moles of ethylene oxide)
(B.D.H. Chemicals Ltd., Poole, England).
Toluene (B.D.H. Chemicals Ltd., Poole, England).
PPO: 2,5-Diphenyloxazole (Koch-Light Laboratories Ltd., 
Colnbrook, England).
POPOP: 1,4-Di 2-(5“phenyloxazolyl) benzene (Koch-Light 
Laboratories Ltd., Colnbrook, England).
Nitromethane (B.D.H. Chemicals Ltd., Poole, England).
4.6 Autoradiography.
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Emulsions: Ilford K5 Nuclear Research Emulsion in Gel 
Form (llford Ltd., Ilford, England). Agfa-Gevaert 7.15 
Nuclear Emulsion (Agfa-Gevaert, Belgium).
Developers: Kodak Microdol-X (Kodak Ltd., London). 
Agfa-Gevaert G170c (Agfa-Gevaert, Belgium).
Ilford Hypam Rapid Fixer (llford Ltd., Ilford, England).
Meyer’s Haematoxylin comprised: 0.5g Haematoxylin (B.D.H.) 
O.lg sodium iodate, 25g aluminium ammonium sulphate (ammonium 
alum), 0.5g citric acid and 25g chloral hydrate made up to 
500ml.
DPX slice mountant (B.D.H. Chemicals Ltd., Poole,
England).
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METHODS
5*1 Animals and partial hepatectonry.
Four to six week old male rats, Mus norvégiens of the 
Hooded Lister strain, random hred and weighing between 80-150g 
were used. Rattua rattus of the same age, weight and sex were 
used only in the thymidine kinase experiments.
Partial hepatectoray of approximately two-thirds of the 
liver — median and left lateral lohes — was performed under 
ether anaesthesia by the method of Higgins and Anderson (l9Jl) 
Partial hepatectoray was carried out between 6 a.m. and noon 
to minimise diurnal variation in regenerative ability (Bucher, 
1963; Bade et al. 1966). Animals were allowed food and water 
ad libitum. 5^ dextrose being substituted for water following 
operation. The rats were maintained at approximately 22®.
5.2 Thymidine Kinase Activity.
Thymidine kinase activity was determined in vitro by 
the method of Ives, Durham & Tucker (I969)* In this method 
disks of anion—exchange paper are used to retain nucleotides 
(TMP, TDP and TTP) formed by the reaction, while the precursor 
nucleoside (TdR) is washed away. The use of the isotopically 
labelled precursor enables the formation of product to be 
followed by liquid scintillation counting.
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The enzyme was extracted hy preparing a I/5 (g liver [ 
V O.25M sucrose) homogenate. The homogenates from control and 
Myleran-treated rats were assayed for thymidine kinase activity 
at 1/5, 1/25 and I/25O (w/v) dilution of liver / 0.25M sucrose, 
as follows t
An equal volume of reaction mixture, containing Tris-HCl 
(pH S.O^^o), 5OÆ; ATP, MgCl^ , 2.5mM and thymidine,
O.OSmM was added to the homogenate. The mixture was then 
incubated at 37^ for 30 min. The reaction was halted by plac­
ing the ends of the test-tubes containing the mixture into a 
water bath at 100®. After centrifugation 20 jxl aliquots of 
the supernatant were applied to 23mm diameter disks of DEAE 
substituted paper. After standing for 10 min the disks were 
washed for 20 min in O.OOIM ammonium formate (30 ml . per disk). 
This procedure was repeated and the disks given an additional 
three rinses in water. The disks were then placed in glass 
scintillation vials. 1.0 ml of aqueous HCI/KCI (0.1/0.2M) 
was added and the vials were gently shaken for 15 min to elute 
the labelled nucleotides. After elution was complete 10 ml 
of Triton—toluene scintillation solvent was added and the 
radioactivity of the samples determined. Control rats were 
assumed to have 100^  kinase activity and the thymidine kinase 
activity in rats given l^leran was expressed as a ^  of the 
control value.
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5*3 Pmg and Thymidine Injections.
Myleran (4.4mg /Kg hody weight) was dissolved hy 
grinding with 1 part of dimethyl sulphoiide in an agate mortar* 
Nine parts of arachis oil were then added with further grinding 
both to allow prolongation of drug action and reduce peritonitis 
associated with intraperitoneal administration of the solution 
(Elson et al. 1970? Dunn & Elson, 1970). 0.5 ml doses of
Myleran emulsion, or drug free emulsion for controls, were 
given intraperitoneally before completion of suturing except 
where otherwise indicated.
For measurement of DNA synthesis and the labelling in­
dex partially hepatectomized rats were injected at intervals 
of approximately 6hr. following the operation with [g-^ h] 
thymidine (0,5yiCi /g body weight, made up to 0.5 ml with 
normal saline (0.I5M sodium chloride)). They were killed 45 
min (Prayssinet et al. I968) after administration of the isot­
ope. In the case of rats being used for the determination 
of the fraction of labelled mitoses 0.5 ml [ô-^ h] thymidine 
was injected l6hr. following partial hepatectoray and rats 
were killed at hourly intervals. The dose of isotope 
administered was selected as giving good autoradiographs 
within a 2 week exposure time without causing radiation 
injury (Post & Hoffman, I96I; Grisham, I960).
The control rats used were of the same age, weight.
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sex and strain and.were treated in the same manner as their 
experimental counterparts. Experimental animals were given 
intraperitoneally 0.5 ml of a mixture of dimethyl sulphoxide 
and arachis oil (l:10, v/v) containing 4.4mg Myleran /Kg hody 
weight, and later 0.5^Ci [s- h^ ] thymidine /g hody weight 
intraperitoneally, made up to 0.5 ml with 0.15H saline.
Controls were given the same injections, but without Myleran.
5*4 Nucleic Acid Extraction.
Nucleic acids were extracted by a modification of the 
Schmidt-Thannhauser procedure as detailed by Munro (1966): 
this procedure requires no lipid extraction prior to that of 
nucleic acids. Excised liver was immediately transferred to 
iced water, weighed and a 1.5/20 (w/v) homogenate prepared 
using a Potter-Elvehjem tissue homogeniser. A Ihr. incubation 
at 37^  in 0.3M potassium hydroxide solubilized RNA and three 
30 min extractions at 70^  with l.OM perchloric acid were used 
to extract DNA. The extractions were carried out in 10 ml Py­
rex homogenisation tubes capable of withstanding centrifugation 
at 3,000 r.p.m. thus facilitating washing and preventing 
errors in transference. All procedures were carried out at 0 .
5.4.1 Assay of Nucleic Acids
RNA was determined spectrophotometrically using quartz 
cells with a 1cm light path in a Beckman DB 1402 spectrophoto-
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meter. The concentration of ENA. was calculated from the 
formula:
E^NA “ ^260na “ ^232nm ^ B*gg, 1965)
where:
^RNA “ concentration of RNA in yug RNA-P per ml of solution.
*260nm ^232nm ~ absorbance of the solution measured at
260 and 232nm respectively.
DNA was estimated by Giles and Myers* (I965) modific­
ation of the Burton diphenylamine method as the latter method 
gave unacceptably high blank readings. One volume of test 
solution, one volume of 4^ diphenylamine and 0.05 volumes of 
acetaldehyde containing 1,6 mg ml ^ in aqueous solution were 
mixed, incubated at 30  ^for l6hr. and the absorption at 595 
and ?00nm read against a suitable blank. The difference in 
absorption (595 — 700nm) was used to determine the DNA content 
of samples by comparison with a standard solution of calf 
thymus DNA. The phosphorus content of the standard calf 
thymus DNA solution was measured by the method of Allen (l940). 
Results were expressed in terms ofy4g DNA-P /g liver remnant.
5*5 Percentage Regeneration.
Percentage regeneration was calculated from weights of 
wet liver excised at time of operation and at death.
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iû Regeneration = Increase In raasa of liver after benatectomy x 100 
Mass of liver removed at partial hepatectomy
The fraction of liver excised at operation was established at 
70.2^  by direct measurement. This value together with the mass 
excised was used to calculate the weight of liver remaining 
in experimental animals following partial hepatectoray.
5*6 Liquid Scintillation.
Assay of radioactivity in the DNA fractions was carried 
out with a Packard Tri-Carb liquid scintillation counter by 
the emulsion technique of Patterson and Greene (1965)* Scint­
illant was prepared by mixing 1 volume of Triton X-100, 
purified by stirring with l/lOth part by volume of silica gel, 
to 2 volumes of toluene containing 0,4ÿ PPO and 0.01^ POPOP. 
Quench curves were prepared by the addition of 8-10yil of 
nitromethane to vials containing 10 ml of scintillant and 1 ml 
of l.OM perchloric acid containing a known amount of tritiated 
thymidine. One ml of the l.OM perchloric acid DNA extract 
mixed with 10 ml of scintillator mixture was counted with an 
efficiency of about 27^ . Thymidine incorporation is expressed 
as the specific activity of the DNA fraction in d.p.m. / 
yig DNA-P.
5.7 Histological Preparations.
It has been shown in resting and regenerating liver
— $6 —
that proliferative cell populations are distributed uniformly 
throughout the lobes of the liver remnant (Fabrikant, 1964).
For all studies the right lateral lobe was used and considered 
representative.
Animals were killed by heavy ether anaesthesia and 
exsanguination. Portions of liver l-2mm thick were placed in 
fixative (20 parts ?0^ ethanol, 2 parts 10^ formalin (Ca CO^ 
in excess) and 1 part glacial acetic acid) for 24hr., 
transferred to ?0^ ethanol, and after dehydration in increasing 
alcohol strengths, cleared in toluene and mounted in histological 
wax by vacuum embedding after thorough infiltration. Microtome 
sections 4 to 5 micrometers thick were obtained using a Beck 
rotary or MSE sledge microtome.
5.8 Autoradiography.
The emulsion dipping procedure for high resolution 
autoradiography was selected (Bogoroch, 1972; Lord, 1963;
Baserga & Malamud, 1969)* The liquid photographic emulsion 
used was Ilford K5 Nuclear (Gevaert Scientia 7*15 was also 
used) with grain size of the order 0.2 micrometers. After 
being brought to water by passage through toluene (ihr.) and 
decreasing strength alcohols, tissue sections were dipped in 
emulsion, diluted 1:1 (v/v) with 2% glycerol at 43^,and dried 
vertically at 25® and 75^ relative humidity to minimise 
background. Slides were stored at 4® in light-tight black
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boxes In the presence of silica gel. A dry atmosphere mainta­
ined in this manner was found to be essential for proper 
development.
A 'cold* and *hot* standard were present in each box.
The cold standard was a non-radioactive section. A heavily 
labelled slice, taken from the regenerated liver of an animal 
injected l6hr. after partial hepatectoray with 0.5y*Ci /g body 
weight of tritiated thymidine and killed 22hr. after partial 
hepatectoray, close to the mitotic labelling peak, was used as 
the hot standard. The cold and hot standards were used to 
evaluate the background labelling and reliability of the method. 
The cold standard had generally less than 1 grain per cell. 
Batches of slides with a cold standard having greater than 
this amount were discarded. For the hot standard parameters 
investigated were;
i) the average label per mitosis, 
ii) the number of labelled nuclei per hundred cells. 
Batches of autoradiographs in which the hot standard had less 
than 18 grains per mitosis and less than 20 labelled nuclei 
per 100 nuclei were discarded. Additionally individual slides 
having a high background were discarded.
All histological preparations were examined using an 
oil immersion lens (magnification 1300x) on a Vickers Patholux 
binocular microscope.
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The exposure time selected vas two weeks. Slides were 
developed at room temperature with Kodak Microdol-X (and in 
some instances with Gevaert G170c, with comparable results) 
for 3 min, washed in fresh Vfo acetic acid for 10 sec, fixed in 
1:4 (v/v) Hypam /water for 2 min and washed in running 
distilled water. Sections were stained with Meyer's Haematox- 
ylin and eosin (Bogoroch, 1972) and then dehydrated and cleared 
to minimise artifacts as follows (Bogoroch, 1972): 2 min in 
95/^  ethanol, 4 min in absolute ethanol, Ihr. in 1:1 (v/v) 
absolute ethanol /cedarwood oil, Ihr. in 1:1 (v/v) toluene / 
DPX. After mounting in DPX, slides were dried at room temper­
ature. Parenchymal cells were scored as labelled if an arbit­
rary lower limit of 5 grains per nucleus was exceeded.
5.9 Determination of Cell Cycle Phases by the Method 
of Labelled Mitoses.
The times of the G^ , S, G^  and M phases and were 
determined by the technique of labelled mitoses (Pabrikant, 
1968a). The fraction of labelled parenchymal cell mitoses 
was determined at hourly intervals after injection of 
tritiated thymidine by the method of Quastler & Sherman (l959)«
The time of prophase was obtained from prophase and 
metaphase labelling curves, while the times of the other mitotic 
phases were obtained from the ratios ;
Metaphase time = Prophase time x 9® Metaphase population
t^Prophase population
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Anaphase time = Prophase time x 9^ Anaphase population
9^  Prophase population
Telophase time = Prophase time x 9^ Telophase population
9^ Prophase population
(Post et al* 1963)•
Partially hepatectomized rats were injected with 
0*5y<Ci /g hody weight thymidine l6hr* after operation.
They were killed at hourly intervals and the excised livers l 
added to fixative. After blocking and slicing, as described 
previously (5*7)» & minimum of four slides were studied 
autoradiographically (5.8). One hundred mitoses were scored 
for each rat.
The means and standard deviations of G^ , S and Gg 
phase durations were also estimated by plotting the fraction 
of the labelled mitoses on probit paper by the method of 
Okuraura, Gnozawa, Morita & Matsuzawa (l973)« This method 
assumes the frequency distribution of the duration of each 
phase to follow a normal distribution. The values were 
compared with the values found from a Monte Carlo programme 
(Barrett, 1966); this requires iteration of a simulated 
labelled mitoses curve until simulated and experimental curves 
are consistent.
5.10 Mitotic Index and Abnormal Mitotic Figures.
The mitotic index was found by counting the number of
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fields necessary to score 100 mitoses and from a determination 
of the number of cells /field. The mitotic index was 
corrected for the increasing mass of the liver (Fabrikant,
1968). The corrected mitotic index may be defined as the 
total number of parenchymal cells proliferating in the liver 
remnant at the time of observation expressed as a fraction of 
the number of cells in the remnant at the time of partial 
hepatectomy (Fabrikant, I968).
Concurrently with the determination of mitotic index 
the proportion of abnormal mitotic figures was noted. The foll­
owing criteria of abnormal mitotic figures were taken (Horst:
& Rudnicki, I962):
a) Prophase: the dominating feature was taken as an 
abnormally formed chromatin network which appeared homogeneous 
and without the typical filamentous structure, with occasionally 
final nuclear dissolution and irregular chromatin clumps in the 
cytoplasm,
b) Metaphase: abnormal figures were characterised by 
interrupted connection of some chromosomes with the spindle, 
clumping of chromosomes into a homogeneous circular formation 
or chromosomal fragmentation,
c) Anaphase: irregular distribution of chromosomes, 
fragmentation and chromosomal bridges.
d) Telophase: pseudo amitosis, acentric fragments and 
micronuclei.
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5,10.1 Corrected Mitotic Index
The mitotic index gives the proportional number of 
cells in mitosis. In order to provide a measure of the total 
number of cells in division the mitotic index must be corrected 
for the increasing mass of the liver remnant on regeneration 
(Fabrikant, I968). The estimate of the liver size, taking 
the size of the liver remnant at partial hepatectomy as unity, 
was based on the hypothesis that at the end of each 2hr. 
period a number of cells equal to the number in mitosis  ^
during this period was added to the cell population. The 
number of cells in mitosis was determined from the mitotic 
index at the end of the 2hr. period and the estimated number 
of cells at the beginning of the period.
= "It : Ht
where:
MI^ = observed mitotic index; fraction of cells in
mitosis at time t.
CMI^ = corrected mitotic index at time thr. after
partial hepatectomy.
H. = number of cells in the liver at time t expressed t
as a fraction of the number of cells in the liver remnant at 
the time of partial hepatectomy.
For a mitotic length of Ihr. (Fabrikant, I968) after nhr.:
\  = ("It ' * V a ) —  + (”^t-(n+2) '
«t-(n.l)) * (":t-(n+D :
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RESULTS
6,1 DNA Synthesis in Regenerating Liver•
The rate of DNA synthesis is generally measured hy 
the incorporation of radioactive tracers, thymidine usually 
being used for this purpose. Maximal incorporation of radio­
active thymidine into the acid soluble nucleotide fraction 
and DNA of regenerating liver occurs within 10 min of intra­
peritoneal injection (Chang & Looney, 1965)* The use of 
labelled thymidine to measure DNA synthesis has been criticised 
because thymidine has been found to bind to proteins in 
hepatocytes (Morley & Kingdon, 1972) and to a DNase resistant 
part of the mouse cell cytoplasm (Bryant, 1966), The thymidine 
used in both the above studies was labelled in the methyl group, 
which is perhaps more labile than the 6 labelled thymidine 
used in the present study. The controls, injected with label­
led thymidine but without Myleran eliminate this source of 
error.
The rate of DNA synthesis was estimated at various 
times following partial hepatectomy by the incorporation of 
6^— thymidine into the regenerating liver remnant. The 
[ô— thymidine was injected intraperitoneally 45 min before 
sacrifice and its incorporation into DNA measured by liquid 
scintillation counting (5,6).
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Incorporation of 6-^H thymidine in the regenerating 
liver per-g_wet weight of liver for control and Myleran- 
treated rats is shown in Fig, 2; the resultant specific activity 
of the thymidine labelled DNA (d.p.m.^g DNA-P)is shown in 
Fig, 3* Table 1 summarises the effect of Myleran on the DNA 
synthetic rate at the peaks of DNA synthesis, as shown in Fig, 3*
For each rat the DNA content /g wet liver was determined 
in duplicate, for two liver samples. The specific activity of 
extracted DNA was also measured in duplicate for each of the 
liver samples. The standard deviation at each point ( (^ ) was 
calculated from the formula (Beyer, 19^ 8):
where;
 ^^ = d,p,m, /g wet liver (Fig, 2) or specific 
activity of the DNA fraction (Fig, 3) for each of the values 
1—^ n,
S = the mean of the X values,
n = the number of rats used at each point.
Three peaks of DNA synthesis, at IShr,, 30hr, and 58hr,, 
were found during the first 72hr, of liver regeneration,
Myleran does not appear to alter the times at which DNA synth­
esis is maximal, with measurement of the rate of DNA synthesis
— 64 —
o +>
lA CO
0 
CO
01
o
-4*
CM
O
O
CM
O
VÛ
H
O
CM
H
O
00
O
C -
OT X (aoATX S/*m*d-p)
'O
Pt G
0> -d
> a
•H m A
r—1 1— 1 CD
o P
4* M X i CD
CO P p 03
H G CO
to
O CD CD
Ü T3 to
a CO
•H (D A
+»
CO G
CD
>
<0
m CD
c CD ,Q CD
? H X i% CD G p
CD > •H
H
A
8 00
p
O ir\ G
"4- CD
% CO
-H CD CD
CD c G A
> o •H A
-H •G CD
-P P A
CD CO a
A
CD
P
GO A P •H
+» O O
A
CD %  m
> AO
•H -rH 1 O
+> > VO CO
CO O' M
1—C 1—1
CD 1—1 ^
H o p
•H c
CD > o
G >> •H
•H r-C P
no P r—C CO
•H O 1—1•H
e CD CO
>> A CD CD
•H G •a
+» T3 O
P TD
G •H A
LO A COro A CD no
1 CD A G
VO 1—1 CO CO
A P
4-c
P 00
G
O c
CD
•H CD
G > n3P
O •H CD
-H ta p P
■P O G
CO CD CD
O 0 •r-3G COCD
A •H A
r-t A
o A CD CD CO
o CD A A p
G X i CD CD
•H P
•H
g 01
A
A
CD CD 02 CO CD
PUXi CD
EH CD G aA O r—1
CD & CO pCVJ g o ta•H
m X i P GÏJÛ p p A •H
•H CO o CD 00
P4 pq> G
— 6$ —
VO
VOCO
o
•H
•P
(0
o
ft
o
uo
+>
(0
to
o
A
c
o•H >>
+» r-t
CO iH 
H  CO CO 
CD <D n-i ft C 0 0 4*
tjO *H "H 
G  M  O  
•H CD ft 
^  ft 
O  CO ^  
r4 M  O  iH +>
o a H
c-
OT X (d-VNQ STi/*ui*d*p)
• 4h t4
G
O >> CD
•ri 1— 1 G G
+» 4* •H O
O . O 03 •H
CO CD •H 4*
M F4 a cO
«H •H i4
03 >
4* m
îs; G no
A cOr'“ 1 00
Fh pq TO 4*
Q> oro FH CO
A 1—1 I CO FH
+» >3 VO 03
S i--1 C CD
CO CD
O G  ^  4*
aCD 4* m
>> > •H 4*
4= •H > CD
•H t»0 Xi a
> no 4» o
-H O H
4»
O 04*O 4*G 44
CO CD CD no
T) CD @
o m G CD G
4* •H Fh •H
Vl CO ft CO
•H M CD CD 4*
O F4 H X
CD G 0> o
ft •i4 ? CD
m Fh CD
m CO D
G G ft Æ  iH
O . o G CO
-H o r4 >
G 4>
&
CO
CO O o ?
.0 •H W
CD A  XI 4» CO
r~i «H 4* FH Fh
>» o <D 0>
a
S
A > >
CO
44 A
O CO G
r4 CO
4* N O +>
44O CD FH CO
CD > 4* CD O
«H -H G •a
<44 1—1 O O
O O CD >
% Fh •H
« C G O 4*
•H •H «H CO
Eh 4* CD 4*
CO X G
rO
FH
CD 0 G
CD
CD
C •H CD
CD a FH
% tsO n3 ft
-H CD G m CD
ft ft CO Fh
* — 66 "
Table 1. The Effect of Myleran on DNA synthesis in Regenerating
Rat liver.
Position of DNA Time (hr.) between DNA difference in peaks
synthesis maxima (hr.) synthetic peaks (control - Myleran)
18
30
58
1st & 2nd 
2nd & 3rd
12
28
55
58
3
Myleran-treated rats were injected with 4.4mg Myleran 
/Kg body weight at operation and 6^- h^J thymidine 45 min before 
death. Control rats were nntreated with Myleran.
^These values obtained from Fig. 3 (DNA specific act­
ivity) were the differences between control and Myleran peaks 
of the thymidine incorporation as a ^  of the respective control 
peaks.
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made at intervals of 6hr. for the first two peaks and 14hr. for 
the third peak (Fig# 3)* A shift in the position of the peaks 
of DNA synthesis of <3hr. for the first two maxima and <7hr# 
for the third maximum, would not he observable for these 
experiments#
The estimate of the. DNA synthetic rate obtained from 
the slope between the points of Fig, 3 is an approximate 
value, due to the large time gap between experimental values# 
Myleran lowers the incorporation of thymidine into DNA, in 
comparison with the rate of incorporation shown by the control 
rats. There is a decrease to 45^ at 18hr. 42^ at 30hr. and 
at 38hr., Table 1. Myleran was injected immediately after 
operation, when the liver parenchymal cells were in the 
phase of the cell cycle. Myleran exerts its greatest effect 
on incorporation of [ô-^hJ thymidine, as seen in Table 1 and 
Fig. 3f between 24hr. and 36hr. following partial hepatectomy.
The areas under the bands of DNA synthesis shown in 
Fig. 3 are proportional to the amount of DNA synthetized 
during their duration. The total DNA synthetized over 12-72hr. 
following partial hepatectomy in Myleran-treated rats and 
controls was estimated from the weight of cardboard cut-outs 
of the graphs of specific activity of the DNA (Fig. 3)« The 
total DNA synthetized between 12-72hr. for the Ifyleran-treated 
rats was found to be 60.3^  of that of the control animals.
Fig. 3 vas used to calculate these values since it is more
— 6s —
accurate than Fig. 2, which depicts the incorporation of [,6-^ h J 
thymidine /g wet weight regenerated liver, due to the difficu­
lty of obtaining an accurate weight for the liver remnant.
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6,2 Thymidine Kinase Activity.
It was felt that the effects of Myleran would he most 
clearly shown at the time when thymidine kinase activity was 
maximal. Ol'shanetskaya, Kavelina & Novikova (1968) and 
Beltz (1962), found thymidine kinase activity to increase from 
18—30hr. in regenerating rat liver. Thymidine kinase activity 
was therefore determined at 30hr. following operation; the 
synthesis of DNA, dependant upon the activity of thymidine 
kinase, is still proceeding at a high rate at this time (6.I).
6.2.1 Analysis of Thymidine Kinase Activity
At 30hr. after operation thymidine kinase was extracted 
and its activity determined hy the method of Ives, Durham & 
Tucker (1969), as detailed previously (3.2). Two rats were 
used for each determination. The value for the activity of the 
enzyme was found to he dependant upon the dilution of the 
homogenate used for the assay. The enzyme activity was first 
determined at a dilution of I/5 (g liver /v 0.25M sucrose) and 
this value taken as unity. The activity found for the I/25 
(g liver /v 0.25M sucrose) and I/25O (g liver /v 0.25M sucrose) 
diluted rat liver homogenates was 8.3 and 73*1 of the activity 
of the original I/5 (g liver /v 0,25M sucrose ) diluted 
homogenate. These values are summarised in Table 2.
Experimental rats were injected with Myleran directly
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after operation. The values of thymidine kinase activity 
for experimental animals were expressed as a ^ of the 
activities found for control rats killed at the same time. 
Thymidine kinase activity in the l/5 (g liver/ v 0.25M 
sucrose) diluted homogenate was lower in those rats given 
Myleran hy an average of 36^ # The values of thymidine kinase 
activity determined for control and Myleran-treated rats using 
a 1/25 (g liver/ v 0.25M sucrose) diluted liver homogenate 
were both greater than the values found for a I/5 (g liver/
V O.25M  sucrose) diluted liver homogenate obtained from 
control rata. At a I/25O (g liver/ v 0.25M sucrose) dilution, 
the values of thymidine kinase activity obtained from control 
and Myleran-treated rats were both greater than the value of 
the 1/25 (g liver/ v 0.25M sucrose) homogenate from control 
rats. At this dilution the activity of thymidine kinase was 
12.5/w lower for rats treated with Myleran than that of the 
1/23 (g liver/ V 0.25M sucrose) diluted control; while at 
1/250 (g liver/ V 0.25M sucrose) dilution, activity was 23^ 
greater for Myleran-treated rats than the control value.
Table 3 summarises the effect of Myleran on the ‘apparent* 
thymidine kinase activity.
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Table 2. Rat Liver 'Apparent* Thymidine Kinase Activity on 
Dilution of Homogenate for Control Animals 30hr. 
following Partial Hepatectomy.
Dilution of Homogenate *Apparent* Thymidine Kinase Activity:
as a fraction of activity of l/5 
diluted homogenate
1/5 1
1/25 8.3
1/250 73.1
The activity of thymidine kinase was determined as 
detailed before ($.2).
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Table 3. Rat Liver A^pparent* Thymidine Kinase Activity 30hr.
after Partial Hepatectomy and Myleran injection.
1/5 dilute homogenate 
Activity ($6 control)
1/25 dilute homogenate 
Activity control)
1/250 dilute homogenate 
Activity control)
61
67
87.5 125
Myleran-treated rats were given 4.4mg Myleran /Kg body 
weight at operation. The control value found in each instance 
was assigned 100^ thymidine kinase activity. Two rats were 
used for each determination.
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6.3 The DNA content of Regenerating Liver.
Fig. 4 depicts the DNA content per g vet weight of 
regenerated liver, for control and Myleran-treated animals 
over the first ?2hr. following partial hepatectomy. The 
DNA was estimated (3.4.1); each point on the graph repres­
enting the average from determinations on three rats. Myleran 
was injected intraperitoneally immediately after partial 
hepatectomy. •
It is not possible to decide by inspection of Fig. 4 
whether there are significant differences between the values 
for DNA-P/ g wet liver for control and Myleran-treated rats, 
since the standard deviations overlap. Student’s t—distribution 
for probability was applied to the results. A ^  probability 
that a difference exists between the mean values for the two 
sets of results at any time point is found from tables of 
T versus U' , where:
2
X = (3 /n , Cj being the standard deviation of a setn a n
of values (n) and n their number.
T = IMEAN^  - MEANg
J
(/ = (x^  + x^f
+
(n^  - l) (&%"
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The results from Student’s t-distrihution indicated, at 
the least probability (at 30hr, and 36hr«), a }>60^  
probability for difference between the two sets of results.
The DNA-p/g wet liver from Myleran-treated rats is approximately 
9/^ above the mean level for control rats between 12-24hr, 
and 36-48hr, following partial hepatectomy; while the value 
of DNA-P/g wet liver for the experimental animals is approx­
imately 10^ below that of the control animals at 30hr. and 
between 58-72hr# These results are summarised in Table 4,
Over the complete 12-72hr, period following operation 
DNA-P/g wet liver in Myleran-treated rats was found to be 
101,3^ in comparison with controls.
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Table 4, DNA-P/g vet Regenerated Liver in Myleran-treated 
Rats compared to the Control Values,
Time (hr,) after ^ difference between Probability for true
partial hepatectomy, Myleran-treated and control difference between values for
rats in DNA-P/g vet liver, Myleran-treated & control rats,
18 3 60-75
24 5 80-90
30 -17 60-75
36 3 60-75
48 22 97.5-99
58 -6 75-90
72 -8 70-75
T^he *jo probability that there was a difference 
between the two sets of values, that for Myleran-treated and 
that for control rats, was determined using Student’s 
t-distribution (6,3).
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6,4 The KNA Content of Regenerating Liver
The change in RNA-P/ g regenerated liver over the 
first ?2hr, following partial hepatectomy is shown in 
Fig, 5 * each point represents the average value for three rats. 
The RNA-P content for hoth control animals and those treated 
with Myleran immediately after operation (5*3) vas greatly 
elevated from 25hr, and remained elevated up to 72hr* A peak 
in the RNA-P content occurred at 36hr, with a gradual fall to 
72hr,
RNA-P/g wet liver is raised in Myleran-treated rats, 
in comparison with those values found for the control rats, 
hy 9^ at 12hr, and 30br, and 10^ and 8^ at 48hr, and 58hr, 
respectively; while the value is 4^ lower than that found for 
controls at IShr, after operation. The probability for there 
being a difference between control values and values for those 
rats that were treated with Myleran was found by calculation 
using Student’s t—distribution to be ^ 70% at each of these 
times. Probability values indicated that at other times after 
partial hepatectomy there was no difference in the values for 
ENA-P/g wet liver between control and Myleran-treated rats.
Table 5 summarises these findings. Over the complete 12-72hr, 
period following partial hepatectomy RNA-P/g wet liver in 
Myleran-treated rats was found to be 104^ of the control value.
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Table 5# RNA-P/g vet weight Regenerated Liver In Myleran-treated 
Rata compared to the Control Values,
Time (hr*) after difference between Probability for tme
partial hepatectomy, Myleran-treated and control difference in vaines for
rats in ENA-P /g wet liver* Myleran-treated & control rats,
12 9 75 - 90
18 -4 70 - 75
24 0 <60
30 9 70 - 75
36 6 <60
48 10 97.5 - 99
58 8 7 5 - 9 0
72 0 <60
^The io probability that there vas a difference between 
the two sets of values, that for Myleran-treated and that for 
control rats, was determined using Student’s t-distribution
(6.3).
80 —
The initial (l2hr*) and final (72hr.) determinations 
of RNA content in the control rats agree with published 
values: 608yig RNA-P/g vet liver before regeneration
and 7 4 9 HNA-P/g vet liver after regeneration (Pai, 1964)*
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6*5 Restoration of Liver Weight
Fig* 6 shows restoration of liver weight in Myleran- 
treated and control rats over the first 72hr. following 
partial hepatectomy* Rate of regeneration, represented hy the 
slope of the curve (Fig* 6) is most marked during the periods 
12-30hr* and 36-48hr* following operation* It can he seen 
that the control curve of Fig* 6 has large standard deviations 
for each mean value, overlapping the standard deviations 
found for the values for Myleran-treated rats, even though three 
to sixteen rats were used at each time interval* By inspection 
therefore, it is not possible to see if the two curves of Fig* 6 
differ* Student’s t—distribution however, shows there to he a 
>80^ probability for difference between the mean values for the 
Myleran-treated and control rats at I2hr* and between 24-58hr* 
Myleran-treated rats being 68^ and 3^^ less restored in weight, 
compared to the controls, at these respective periods* At 72hr* 
Myleran-treated rats are 9^ less regenerated in weight in comparison 
with untreated rats: that the difference is significant is shown
by the probability value of >70/^ . Measurements of liver weight 
regeneration at 18hr* for the drug-treated animals are not 
significantly different from those of the control rats when these 
values are compared using Student’s t-distribution* These results 
are detailed in Table 6* By comparing the area under the curves 
of Fig* 6 between 12-72hr*, which gives a measure of total 
regeneration in weight of the liver, Myleran-treated rats were 
found to be 73^ regenerated in comparison with the control value*
—  82 "
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Table 6, Restoration of Liver Velght between 12-72hr. after 
Partial Hepatectomy in Myleran-treated rata 
as a ^  of Control.
Time (hr.) after Restoration of Myleran- Probability of difference
operation. treated livers control), between Myleran-treated &
control values being real.
12 33 80 - 90
18 • 100 <60
24 55 95 - 97.5
30 56 85 - 90
36 83 80 - 85
48 68 90 - 95
58 68 90 - 95
72 92 70 - 75
^The ^ probability that there was a difference 
between the two sets of values, that for Myleran-treated and 
that for control rats, was determined using Student’s 
t—distribution (6.3).
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The rate of regeneration regeneration/time) for 
Myleran-treated rats as a 9^ of the rate shown hy control rats 
is shown in Table 7* The rate of regeneration, as measured 
from the slope of Fig. 6, is decreased in the Myleran-treated 
animals to 36^  of the control rate between 12-30hr. and hyjo 
of the control rate between 36-48hr. Myleran does not affect 
the rate of regeneration over 48—58hr. There is a less sharp 
decline in the regenerative rate for Myleran-treated rats 
between 30-3Ghr. than observed for the control rats. Between 
58-72hr. Myleran-treated rats have a very low regenerative 
rate.
The rate of regeneration found in the present work us­
ing liver weight measurements for control rats, over the first 
30hr. after partial hepatectomy, agrees well with the following 
values found by Fabrikant (1964): 10, 18, 31 and 38^ regenera­
tion at 12, 18, 24 and 30hr. respectively after partial 
hepatectomy.
—  85 "
Table 7. Rate of Regeneration (jo regeneration / time) of Liver 
from Myleran-treated Rats, aa a 9^ of control 
between 12-58hr. after Partial Hepatectomy.
Time (hr.) between which 
rate was measured.
Rate of Regeneration of liver
from Ifyleran-treated rats as a ^
of the rate shown by untreated controls.
12
30
36
48
30
36
48
58
36
-13
43
100
Between 30-36hr. there was a negative rate of 
regeneration for both control and Myleran-treated rats.
. —86 —
6,6 The Lengths of the Mitotic Phases in Regenerating 
Rat Liver,
Partially hepatectomized rats treated with Myleran 
immediately after operation and untreated controls were given 
a ’pulse-lahel* of ^6— thymidine at l6hr, after operation 
(5*3)• The rats were sacrificed at hourly intervals from 
3-12hr, after the injection of [6-^nj thymidine. Sections of 
the liver remnant were prepared and examined hy the emulsion 
dipping procedure for autoradiography (3.8), After autorad­
iography those cells that had incorporated the tritiated thym­
idine were seen to be labelled by the presence of silver grains 
in the overlying emulsion. Total mitoses and cells in prophase, 
metaphase, anaphase or telophase were counted and scored as 
either labelled or unlabelled.
Mitotic labelling curves were drawn for each of the 
four mitotic phases, for both control and Mÿleran-treated ' 
rats, between l6hr, and 28hr, after partial hepatectomy. Fig, 7 
and Fig, 8, The prophase and metaphase ^  labelling curves 
are probably more reliable than the anaphase and telophase 
curves, because of the longer time taken for these stages of 
mitosis; this results in an increase in the number of prophase 
and metaphase stages seen under the microscope. Fig, 9 shows 
the relative ^ of cells in prophase, metaphase and telophase, 
for Myleran-treated and control rats, between 19~28hr, after 
partial hepatectomy.
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Prophase and metaphase nuclei constituted the predominant 
mitotic population and led to the greater accuracy of the io 
labelling curves for these phases (Fig. ?). For each rat used 
for the determination of the io labelled mitotic phases (Fig. 7 
and Fig. 8), one hundred mitoses vere scored. Up to sixteen 
microscope slides, or four thousand fields (5 x 10^  cells) 
were examined for each rat.
The time occupied in prophase was found by the 
difference in time between the first appearance of labelled 
metaphase figures and the first appearance of labelled cells 
in prophase. The respective times were found from the inter­
cepts of the ascending limbs of the 9» labelled metaphase and 
prophase curves of Fig.7# It was not possible to find the 
times of metaphase or anaphase in this manner as the intercept 
on the abscissa of the ascending limb of the anaphase curve 
(Fig.8) was identical to that of the metaphase curve (Fig.7), 
for both Myleran-treated and control rats. The use of this 
method would give a value of zero for the time spent in 
metaphase and consequently an inaccurately long time spent 
in anaphase. The lengths of metaphase, anaphase and telophase 
were calculated, using the premise that the time interval 
occupied by a class of mitoses is proportional to the frequency 
of occurrence (5.9)# The number of cells in a phase being 
calculated over 19-28hr. after operation.
The lengths of prophase, metaphase, anaphase and
— 91 •*
telophase were 1.1, O.65, 0,18 and 0.09hr. for Myleran- 
treated rats and 1.5, 0.9^, 0.21 and 0.06hr. for controls, 
respectively. These values are given in Table 8. A 
total mitotic time of 2hr. for Myleran-treated rats and 
2.5hr. for the controls is obtained on summation of the 
values found for the lengths of the individual mitotic 
phases.
The lengths of prophase and metaphase found in control 
rats (Table 8) correspond closely with the l.^ hr. and Ihr., 
respectively, found by Post et al. (19^ 3) in neonatal rat 
liver.
- 92 -
Table 8. Estimation of the Length of Individual Mitotic 
Phases in Regenerating Rat Liver.
Phase of Mitosis Control rats: Myleran-treated
Time (hr.) in phase. rats: Time (hr.) in phase.
PROPHASE
^lAPHASE
^ANAPHASE
^TELOPHASE
1.3
0.94
0.21
0.06
1.1
0.65
0.18
0.09
Hîetaphase, anaphase and telophase times were estimated 
from equations relating the population of cells in a phase 
to the length of the phase ( 5.9 )*
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6*7 The Incidence of Mitotic Abnormality in 
Regenerating Liver*
Sections of liver vere prepared for Myleran-treated 
and control rats 20-48hr. following partial hepatectomy 
( 5*7 ) nnd examined for mitotic abnormalities ( 3*10 ).
In general, for both Myleran-treated rats and controls two 
animals were used at each time interval* For each rat np to 
eight microscope slides or two thousand fields (2*5 % 10^ cells) 
were examined and at least fifty mitoses were scored* The 
mitoses were differentiated as either normal, or abnormal; 
the abnormal phases were distinguished as being in prophase, 
metaphase, anaphase or telophase* The type of abnormality 
within a particular phase of mitosis was not recorded.
The total number and ^  of abnormal mitotic cells in 
each phase for the period 20-48hr, following partial hepatectomy 
are shown in Fig. 10, 11, 12, and 13 for normal and Myleran- 
treated rats. Prophase and metaphase nuclei constituted 
the predominant mitotic population (Fig. 9)j the greater 
frequency of their occurrence allowed a better estimate of 
their 5» abnormality to be made than for the abnormalities of 
anaphase and telophase.
There are a large number of abnormal prophase cells 
for both Myleran-treated rats and control animals (Fig. lO).
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The numher of prophase figures throughout the period 20-48hr. 
after partial hepatectomy are not markedly depressed following 
ïfyleran administration, although a maiimum in the numher of 
prophase figures, found at 2$hr. following operation in cont­
rols, is absent for Myleran-treated rats. Between 20-24hr. 
after operation the ^  of abnormal prophases is increased for 
Ifyleran-treated rats. Abnormal metaphase figures (Fig. ll) 
are, similarly, higher for Myleran-treated rats than controls 
between 20-24hr. following partial hepatectomy. No consist­
ent effect of 1^1 eran on the ^ of abnormal prophase and 
metaphase figures is seen later than 24hr. after operation 
and Myleran injection (Fig. 10 and il).
An elevation in the number of abnormal anaphase figures 
is seen at 24hr. after operation in )^1eran-treated rats though 
no significant effect of Myleran is apparent in the /é of abn­
ormal anaphases over the whole 20-48hr. period (Fig.12). The 
large value for the ^ abnormal anaphase cells at 25 and 40hr. 
is based on a low number of anaphases. The incidence of abn­
ormal telophase figures (Fig. I3) was negligible for both 
Myleran-treated rats and control animals except at 24hr. A 
high ^  of abnormal mitotic cells in telophase at this time 
was based on an average of only four mitoses in this phase 
for each of the three rats examined.
Examples of normal and abnormal mitotic figures found 
in the liver remnant of rats injected with Myleran immediately 
following partial hepatectomy are shown in Fig. 14,15, I6 and 17»
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Fig, 14. Examples of abnormal prophase figures in the liver 
remnant following partial hepatectomy and Myleran 
injection.
In the upper photograph the chromosome network is homogeneous, 
while in the lower there is nuclear dissolution.
Magnification: Approximately 3000x,
— 100 —
Fig. 15» Examples of normal and abnormal metaphase figures in 
the liver remnant following partial hepatectomy and 
Myleran injection.
The upper photograph shows a normal metaphase cell in which 
the chromosomes are arranged centrally on the spindle. The 
lower photograph shows an abnormal metaphase figure in which 
the chromosomes are clumped, while immediately above it is a 
normal metaphase, in which the chromosomes attached to the 
spindle are drawing to opposite sides of the cell.
Magnification; Approximately 3000x,
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Fig. 16. Examples of abnormal anaphase figures in the liver
remnant after partial hepatectomy and Myleran injection,
The upper photograph shows centrally an abnormal anaphase cell 
in which there is irregular distribution of the chromatin to 
one pole of the spindle. The lower photograph shows chromos­
omal interconnections, even though the chromosomes have reached 
the poles of the spindle.
Magnification: Approximately 3000x.
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I
i
Fig. 17» Examples of abnormal telophase cells in the liver
remnant after partial hepatectomy and Myleran injection,
The upper photograph shows a polyploid cell in telophase with 
both an enlarged nucleus and an increased number of chromosomes. 
The lower photograph shows pseudo amitosis.
Magnification; Approximately 3000x.
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6.8 The Mitotic Index during Liver Regeneration.
The ^  mitotic index was determined at hourly intervals
between 20-26hr. after partial hepatectomy :for rats given
Myleran directly after operation. For control rats the ^
mitotic index was determined at hourly intervals between 20-
26hr, and two hourly intervals between 26-30hr, after partial
hepatectomy. The ^  mitotic index for rats treated with îfyleran
directly after operation and controls are shown in Fig, 18,
The standard deviations at each point were derived from
measurements on at least two rats; for each rat 100 mitoses
were found by examination of up to l6 microscope slides or
/ 4\four thousand fields (5 x 10 ) cells. The derived curves 
(3.10,1) which express 9» mitotic index relative to the number 
of cells in the liver remnant at the time of partial hepatect­
omy are also given in the figures.
In both Myleran-treated rats and controls (Fig. 18) 
there is a base level of approximately 0.13^  of cells in mito­
sis 20hr. after partial hepatectomy, rising to a first peak 
at 22hr, of 2^ of the cells in mitosis. At 23hr. Myleran 
causes a fall in the mitotic index from a value of 1,7^  in 
controls to zero. The mitotic index at 24hr, after operation 
is 3,7^ in control rats but 9.6^ in Myl eran-tr eated rats. The 
rise in mitotic index in the Myl eran-tr eated rats at this time 
is accompanied by a large increase in the ^  of anaphase and 
telophase abnormalities (Fig. 12 and Fig. I3). Student's
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t-distribut!on (6*3)* gives a probability of 60-75^  for diff­
erence between the mean values for control and Myleran-treated 
rats at 23hr* after partial hepatectomy and an 85-909^ probabil­
ity for difference between the meand at 24hr# Myleran 
decreases the ^  mitotic index at 25hr. to O.35o compared with 
hPfo in controls; the probability for difference of the means at 
this time is 75”9C^* There is no difference between mean 
values of mitotic index at 26hr. since Student's t-distribution 
gives the probability for difference between the means as
Two maxima occur in the mitotic indices of control 
rats; there is a small rise in the value at 22hr. and the 
maximal value occurs at 26hr. after partial hepatectomy.
Maxima at 22, 24 and 26hr, were found for Mylerein-treated rats 
(Fig, 18), Two peaks of mitosis in normal regenerating rats 
were found by Fabrikant (l967)> in addition to a larger peak 
at 26hr, he found a small peak at 22hr, after operation.
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^ g The Effect of Myleran Injected at Different Times Following
Partial Hepatectomy
Eats were partially hepatectomized and injected with 
Myleran, or solvent for control, either at the time of 
operation or at ll-^hr,, 17^hr# and 20hr. following operation.
All rats were killed 26hr, after operation and mean percentage 
labelled mitoses scored using autoradiography on slices 
of the liver remnant.
When Myleran was injected at the time of the operation 
the value for /o labelled mitoses was compared with the
control value of 31^* A  value of 18^^ labelled mitoses was 
found when Myleran was injected ll^hr, after operation. A  value 
of 34/6 labelled mitoses, almost unchanged from the control value 
of 31/6 was found when Myleran was injected 172’ and 20hr, 
following operation. Thus the greatest effect of Myleran on 
mitotic labelling observable at 26hr, is shown if it is 
injected immediately after operation. These results are 
summarised in Table 9 •
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Table 9# The Effect of Myleran on 96 Labelled Mitoses vhen Injected 
at Different Times following Partial Hepatectomy,
Injection Time of injection 
(hr.) after operation.
Mean labelled mitoses ($6) at 
26hr. Number of rats ( )•
MYLERAN
CONTROL
. 0 
Hi 
i7i 
20
as Myleran-treated
57 (2) 
18 (2) 
34 (2) 
34 (2) 
31 (5)
Myleran was injected at different times after partial 
hepatectomy and thymidine injected at l6hr. after
operation. All rats were killed at 26hr, after operation, 
corresponding to lOhr, on the graphs of labelled mitoses 
(Fig. 19). The mean labelled mitoses were scored (5*9) and 
values averaged.
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6,10 The Lengths of the Phases of the Cell Cycle in 
Hepatocytes during Regeneration
Partially hepatectomized Myl eran-treated and control 
rats were pulse-labelled with thymidine l6hr, after
operation and killed at hourly intervals (5*3)• Histological 
preparations were made from the excised liver remnants (5»7) 
and examined using high resolution autoradiography (5,8).
The times occupied in the differing phases of the cell cycle 
were estimated by preparing a graph of the 96 of mitoses labelled! 
by the radioactive thymidine. At least four slides were examined 
for each rat, A minimum of 100 mitoses for each rat were 
examined for the curves of 96 labelled mitoses for both Myleran— 
tref^ ted and control rats (Fig, 19)#
The time taken during the I)NA synthetic period, or S 
phase of the cell cycle, was calculated from the first wave 
of labelled mitoses in Fig, 19# The S period was represented 
by the interval between the 50^  points on the ascending and 
descending limbs of the curve. The duration of the S phase was 
also determined from the interval between the 37^ points on 
the rising and falling limbs of the first wave of labelled 
nitoses. If the times of leaving and entering S phase were 
symmetrically distributed, the distance between the 50^  points 
on the first wave of labelled mitoses would accurately 
represent the mean duration of the S phase. In populations 
of cells so far studied, the times of leaving and entering
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Fig, 19, The fraction of labelled mitoses found in 
regenerating liver.
( O )  Animals treated with Myleran directly following 
operation and (O) controls. Both groups were injected 
with ^6— thymidine at l6hr, after partial hepatectomy, 
which corresponds to the origin of the graph.
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s phase are asymmetric, The shapes of the curves of labelled 
mitoses are such that the time interval represented by the 
width on the graph between the 37?^  points gives a fairly 
unbiased estimate of S (Lamerton, Fry & Quastler,1963)•
The minimal time needed for completion of the 
premitotic Gg phase of the cell cycle is the period between 
injection of thymidine and the first appearance of
labelled mitoses* The average duration of the Gg phase is 
given by the interval between injection of [ô—^h] thymidine 
and 505® labelling of the mitotic figures. The time taken 
for the ascending limb of the curve of labelled mitoses to 
rise to 100^ gave an approximate value for the mitotic phase 
time M, The total time taken for the complete cell cycle 
(T^ ) was estimated in Fig, 19 from corresponding points on 
following waves of labelled mitoses. This was only possible 
in the case of the controls which manifested a second mitotic 
labelling wave for the parenchyma. It was difficult to detect 
a second wave of labelled parenchymal cells since most cells 
fail to divide a second time. There was also a loss of phase 
coherence because of spread in the duration of the G^  and 
Gg phases (the standard deviation Gg= l,lhr,) for control 
rats (Table lO), The length of the G^ phase of the cell cycle 
was calculated from the equation;
G^  = T^  — S — Gg — M. , , , , ( 1 )
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Phase
G. C
{
" 4
4 :
4 :
1, The Length of the Phases of the Cell Cycle in
Regenerating Rat Liver
Phase Length by Phase Length by Standard Coefficient
FLM graph (hr.) Probit Analysis (hr.) Deviation 
d  (hr.)
of Variation
(4 -)
— ' — —
1.1 - - -
5.9 6.7^ 6.0 1.4 .23
5.7 6.6^ 5.7 1.2 .21
4.3 2.9^ 4.2 0.7 .17
3.2 1.5^ 3.2 1.1 .34
2.5 - - -
3.0 - - -
- - - -
13.0 — . — —
(m) rats treated with Myleran directly following
operation and (c) controls.
^The values estimated for the S phase from the 375^
points on the first wave of labelled mitoses.
2The minimal length of the Gg phases is given after 
the mean duration of the Gg phase.
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From the curves of mitotic labelling (Fig. 19) the 
length of the S phase for Myleran treated regenerating liver 
was found to be 5*9hr., using the interval between the 
points on the labelling wave, or 6,7hr. using the 379^  interval. 
The corresponding values for the controls gave S values of 
5.7br. and 6.6hr. The length of the Gg phase was found to vary 
between 2*9 “ 4*3hr. in Myleran-treated rats while the control 
value varied between 1.3 - 3.2hr. The length of mitosis in 
Myleran-treated rats was 2.3hr. while in controls it was 3*0hr. 
The total cell cycle time (T^ ) for the controls was approximately 
13hr. Total cell cycle time (T^ ) was not obtainable for the 
Myleran-treated rats as they showed only one wave of mitotic 
labelling. The length of the G^  phase was also unobtainable 
for Myleran-treated rats, since the T^  parameter was unknown 
in equation (l) relating G^  to the other parameters of the cell 
cycle. For the control rats the length of the G^  phase was 
found to be l.lhr. from equation (l). The above results are 
summarised in Table 10.
The curves of labelled mitoses (Fig. 19) were analysed 
further by means of probit analysis (3*9)# In this method ^  
labelled mitoses were plotted directly on to probability 
paper. Fig. 20 and Fig. 21 show labelled mitoses plotted on 
probit paper for control and Myleran-treated rats respectively.
A normal distribution when plotted on probit paper, gives a 
straight line. It was found that straight lines could be
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drawn through the slopes. The time at the 50^ probability 
level and the period between l6^ and 50?^ probability levels 
of the first two straight lines plotted in Fig. 20, in 
chronological order from the origin, correspond to the 
following means and standard deviations for the controls:
1st straight line Gg Oj,
2
2nd straight line G« + S fOL + QT
 ^ J  ^2 S
where Gg and S correspond to the times spent in these phases
and OL and Ol are their respective standard deviations.
2 ^
Identical equations were applied for the fraction of labelled 
mitoses plotted on probit paper for Myleran-treated rats (Fig. 2l)
Analysis of the labelled mitotic curves in the above 
manner gave the length of the S phase for Myleran-treated and 
control rats as 6.0hr. and 5*7br. respectively, the correspond­
ing standard deviations being 1.4hr. and 1.2hr. The values of 
coefficient of variation { / time spent in the S phase),
showed the determination of the length of S phase for the 
Myleran-treated sample to be less accurate than that for the 
control animals. The values for the length of S phase determined 
by the probit method matched those determined using the 3096 
points on the two limbs of the wave of labelled mitoses of 
Fig. 19.
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Fig. 20. The fraction of labelled mitoses plotted on a prohit 
scale for control rats.
The origin of the abscissa corresponds to l6hr. after operation 
when thymidine was injected.
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Fig. 21. The fraction of labelled mitoses plotted on a probit scale
for rats treated with Myleran directly after partial hepatectomy.
The origin of the 
hepatectomy when
abscissa corresponds to l6hr. following partial 
[6— h] thymidine was injected.
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The lengths of the phases for Myleran-treated
and control rats calculated using prohit analysis gave times
of 4.2hr. and 3,2hr# These values matched those read as the
co-ordinates of the time axis for the 50^ points on the first
limbs of the waves of labelled mitoses of Fig. 19. The
standard deviations for the phase times were p.Thr.
for the Myleran-treated rats and l.lhr. for the controls. The
coefficients of variation ( _ / duration of the G« phase)
2 ^ 
for these values of G^ were 0.17 and 0.34, respectively. The
values for coefficient of variation compare the accuracy of
determination of the given phase times with respect to the
length of the phase.
The results obtained by probit analysis are compared, 
in Table 10, to those found by inspection from the curve of 
96 labelled mitoses (Fig. 19). An examination of the lengths 
of the cell cycle phases found for >^leran-treated and control 
rats, given in Table 10, shows Myleran does not affect the 
length of the S phase; this is approximately 6hr. for both 
control and Myleran-treated animals. The length of the mitotic 
phase (m) is slightly shortened, from 3*0hr. in the controls 
to 2.5hr. in Myleran-treated rats. The duration of the G^ phase 
was altered from 3.2hr. in controls to 4.3hr. in Ifyleran-treated 
rats; the standard deviation of the determination was less for 
the Myleran-treated animals (0.7hr.) than controls (l.lhr.)
The results were considered significant; Student's t-distribution 
applied to the results gives a probability of 75”90^  for the
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validity of the difference between the two values of
The curves of labelled mitoses (Fig* 19) were smooth 
and symmetrical waves with a plateau of 855^  and 899^  labelled 
mitoses between 6—9hr* and 3—8hr. after intraperitoneal 
injection of 6^— h^J thymidine for the Myleran-treated rats 
and controls, respectively. The shape of the curves was 
similar to those found for regenerating liver by Fabrikant
(1964) and Stocker & Pfeifer (1967) and for other cell systems, 
such as the ascites tumour (Okumura, Onozawa, Morita &
Matsuzawa, 1973)* The times of the cell cycle phases compare 
broadly with those given by Fabrikant (1964). These values, 
and those of other workers, for normal, neonatal and regenerating 
liver, are compared with the values found in the present work 
in Table 11.
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Table 11. Cell Cycle Times (hr.) In the Liver of Rat as 
found by Different Authors.
Cell system Lengths (hr.) of the Phases Reference
s ®2 M
Neonatal 9.0 9.0 0.5 3.0 21.5 Post et al. (1963)
Normal - 8.2 - 0.8 - Edwards & Koch (19^ 4)
Regenerating - 8.5 - 0.9 - n
n 3.5 7.5 2.5 1.1 14.5 Fabrikant (1964)
n - 7.2 2 1-1.5 - Stocker & Pfeifer (l9&7)
ft 1.1 6 3.2 3.0 13.0 The present work (c)
n — 6 4.3 2.5 - (M)
In the present work listed above (C) refers to 
control and (m ) refers to experimental rats given Myleran directly 
after partial hepatectomy.
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DISCUSSION
The liver is a conditional cell renewal system (Patt 
& Quastler, 19&3) which in response to partial hepatectomy 
undergoes compensatory hypertrophy and hyperplasia. Its 
regeneration in the rat is dependent upon age, enviromental 
temperature, diurnal time of excision and nutrition. These 
factors were standardised in the investigation of the effect 
of Myleran upon regeneration.
The Effect of Myleran on DNA Synthesis in the
Regenerating Liver.
The specific activity of the DNA (d.p.m^g DNA-P) in 
Myleran-treated partially hepatectomised rats and controls, 
after 'pulse-labelling* with tritiated thymidine shows three 
maxima at 18, 30 and 38hr, Bucher et al, (1961) in contrast 
found two peaks of synthesis in weanling rats at 22hr, and 35hr, 
The earlier (by 4 and 3hr,) position of the first two peaks, 
found in this study, may be accounted for by the younger age 
of the rats used, Bucher et al, (1961) found only one peak 
of DNA synthesis, occurring at 25hr, in four month old rats.
In one year old rats the peak was shifted to 30-32hr, The 
peaks are sharply delineated and symmetrical in the case of the 
weanling rats and in the present study.
In Myleran-treated rats the maximal rates of DNA
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synthesis, as shown by the incorporation of [ô- h^ ] thymidine 
into the DNA, were significantly reduced in comparison with 
controls (Table l)# From consideration of the time gaps 
between values for specific activity of the DNA a shift in the 
maxima of <3hr*, for the first two maxima, and <7hr#, for the 
third maximum, would not be observable. Shifts in the position 
of an incorporation band would, however, be noticeable by 
differences in the values found at the bases of the maxima, 
provided the time of the S period of the cell cycle remains 
constant. There was no significant difference in the length of 
S phase after Myleran treatment, thus the decrease in values 
found for thymidine incorporation in the Myleran-treated rats 
in comparison with controls are reliable.
DNA synthesis during regeneration, measured by 
tritiated thymidine incorporation, was lowered to SOPp of 
control values over 12-72hr. following Myleran treatment.
The DNA-P/g wet regenerated liver over this period however, 
was the same in both control and Ifyleran-treated rats. The 
decrease in the incorporation of labelled thymidine found for 
Myleran-treated rats may be due to:
a) decreased thymidine uptake by the lymphatics;
b) decreased thymidine absorption from the blood in the 
liver sinusoids into the liver cells;
c) an increase in the size of thé thymidine 'pool*, 
so'diluting' the label;
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d) a decrease in the activity of thymidine kinase or
of other enzymes on the pathway between thymidine
and DNA (Fig, 1; 1,6,6).
e) an increase in the activity of thymidine phosphor— 
ylase (Fig, 1; 1.6,6),
A decrease in thymidine uptake by the lymphatics, or 
decreased absorption of thymidine from the liver sinusoids 
into the liver parenchyma seems unlikely, Chang & Looney
(1965) have found tritiated thymidine to be incorporated from 
the blood into the nucleotide fraction and DNA of cells within 
10 min , so that passage of tritiated thymidine across the 
sinusoid and cell walls must be facile. As regards fluctuation 
in size of nucleotide pools, Bucher & Swaffield (1969) found 
ENA synthesis to increase the precursor pool size. Endogenous 
UTP and CTP pools were expanded by 50% at 5hr, after partial 
hepatectomy and the rate of ENA synthesis rose by 50—100^ 6 
at 3“6hr, after operation. The nucleotide pools are enlarged 
as a result of the stimulus of partial hepatectomy and Myleran 
is unlikely to enlarge the pools further. An effect of 
Myleran on thymidine kinase, the immediate enzyme on the path­
way leading to incorporation of thymidine into DNA was 
investigated and is dealt with below.
'Apparent* Thymidine Kinase Activity.
The 'apparent* activity of thymidine kinase was
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investigated at 30hr. after partial hepatectomy (6*2),
In the crude enzyme homogenate obtained from the liver, 
thymidine kinase, the thymidylate kinases, which convert TMP 
to TDP and TTP, thymidine phosphorlase and the 5* - nucleoti­
dases, as well as non-specific phosphatases, will be present.
The higher nucleotides TDP and TTP, as well as TMP, will be 
adsorbed on to the ion-exchange paper. Thus the 'apparent* 
thymidine kinase activity is the summation of the synthetic 
and catabolic activities of a number of thymidine metabolising 
enzymes.
The variation in the 'apparent' activity of thymidine 
kinase with the dilution of the homogenate used for the assay 
of enzyme activity may be explained by dilution of inhibitors 
of the enzyme; in rat liver this appears to be specific and 
competitive inhibition by TTP (Breitman, 1963), At the 
lowest liver/sucrose dilution of the homogenate (1:5» w/v), 
which is closest to the situation existing in the animal, 
the 'apparent* thymidine kinase activity in Myleran-treated 
rats was only 64% of controls, A graph of ^ activity /dilution 
of homogenate was constructed to find the 'apparent' thymidine 
kinase activity in vivo after Myleran treatment (Fig, 22), 
Extrapolation of Fig, 22 to zero dilution gave an approximate 
value of 40-45% for 'apparent' thymidine kinase activity in 
Myleran-treated rats in comparison with controls. The 
lower rate of tritiated thymidine incorporation (42^ of controls) 
at 30hr. found from 'pulse-labelling* in vivo for Myleran-treated
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rats (6*1) falls vithin this range of ’apparent* thymidine 
kinase activity» The increase in activity on dilution of the 
homogenate for the assay of thymidine kinase may be explained 
by an effect of Myleran on DNA. polymerase» Inhibition of this 
enzyme would cause TTP to accumulate with consequent inhibition 
of thymidine kinase» Since TTP is a competitive inhibitor, 
high dilution would release-inhibition.
Myleran, when injected in the phase of the cell 
cycle, immediately following operation, has its greatest 
effect on the second DNA synthetic peak at 30hr» following 
partial hepatectomy (Table l)» Thymidine kinase has highest 
activity at this time (Beltz, 1962; Ol’shanetskaya, Kavelina 
& Novikova, I968); this lends support to an effect, suggested 
in the present study to be indirect, of Myleran on thymidine 
kinase. Nakai et al. (1966) found a decrease in thymidine 
kinase activity in leukocytes from leukaemia patients after 
Myleran therapy; they did not however, investigate TTP levels 
and the possibility of the effect being indirect.
The DNA Content of Regenerating Liver,
Three minima in DNA-P/g wet liver were found in 
partially hepatectomised Myleran-treated rats at 18, 3O and 58hr, 
(Fig. 4), which correspond to the times of maximal DNA 
synthesis (6.I). Control rats show similar minima at 18 and 
30hr.; the displacement of the third minimum from 58 to 48hr.
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would perhaps be refuted if more rats were analysed at these 
times.
These minima in DMA content are due to large increases 
in cell constituents other than DNA, both before and during 
the periods of rapid DNA synthesis. Triglyceride content and 
compound lipids are elevated, as well as total lipid, over the 
first 48hr, (l,5,2). Amino acid content rises after partial 
hepatectomy (l,5*3) ^nd there is a net increase in protein 
and of the protein synthesising microsoraes, from 12hr. until 
14 days after partial hepatectomy (1.5*4), Concurrent with 
increase of protein content protease activity falls. Nucleo- 
chromosoraal protein synthesis and nuclear histone synthesis 
precede DNA synthesis (l,5*5) and there is an increase in 
pyrimidine synthesis between 12-24hr, after operation (1*6,8), 
ENA and protein are both synthesised in the phase of the 
cell cycle preparatory to the DNA synthetic phase (s) (2),
All contribute to the weight increase of the liver remnant and 
decrease the proportional DNA content.
No difference between control and experimental values 
of DNA-P/g liver were found (6,5), This constancy indicates 
the synthesis of other components is greatly impaired.
The ENA Content of Regenerating Liver*
Church & McCarthy (l967a,b) showed that normally
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repressed embryonic liver RNAs and new short-lived ENA 
molecules are synthesized following partial hepatectomy in 
the mouse; the latter may partially mediate liver regeneration 
and presumably account for the increased RNA content of the 
liver. High molecular weight ENA molecules which may be 
rapidly labelled with radioactive precursors are also produced 
after partial hepatectomy {Mayfield & Bonner, 1972).
Myleran increases ENA-P/g wet liver over the first 
72hr. after partial hepatectomy by 4^ . This value is probably 
not significant and indicates little effect on ENA synthesis.
The Effect of Myleran on Regeneration of Liver Weight,
Measurement of weight of restored liver does not 
always give a reliable indication of the actual hepatocyte 
regeneration. For different animals the weight may vary 
depending on the glycogen content of the liver and the amount 
of blood present in the excised liver, which may be as high as 
505^ of the weight.
Most of the increase in weight of the liver during the 
first three days of regeneration may be due to increased fluid 
uptake (Higgins & Anderson, 1931), This is consistent with 
the data of Harkness (1952), who found liver cells to increase 
in size but not number during the first 24hr, after partial 
hepatectomy. In Myleran-treated rats DNA synthesis is
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depressed by 40$6 and only 739^  of the control weight of liver 
is restored over the first 72hr, There is no difference in the 
io regeneration in weight for Myleran-treated rats and controls 
np to 18hr,, nor in DMA/g wet liver over the whole 72hr, 
period. These results suggest that Myleran has little effect 
on the fluid balance after partial hepatectomy, and that the 
lower weight restoration must be due to decreased DNA synthesis.
The Effects of Myleran on the Lengths of the Mitotic 
Phases in Regenerating Liver,
The lengths of the mitotic phases (prophase, metaphase, 
anaphase and telophase) for Myleran-treated and control rats 
were found to be markedly dependent upon the method used for 
their determination. The estimate of the length of prophase 
obtained from prophase and metaphase labelling curves was 
considered most reliable. The appearance of labelled cells in 
prophase and metaphase after pulse-labelling could be clearly 
distinguished as these phases constitute the larger part of the 
population.
The length of prophase estimated by the above procedure 
was used to find the lengths of the other three mitotic phases 
by substituting in formulae which relate the frequency of 
occurrence of mitotic figures to population size (5,9)# It 
was necessary to use this method to find the length of metaphase, 
anaphase and telophase, since the interval between the first
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appearance of labelled metapbase and anapbase figures vas 
indeterminate, hence invalidating values obtained for 
anaphase. The frequency of occurrence method however, suffers 
from the disadvantage that changes in the number of cells in 
a phase, due to blockage in that or a previous phase, will be 
interpreted as a change in length of that phase# It is seen 
from the of cells in the four mitotic phases. Fig. 9, that 
blockage does not occur in any particular phase after Myleran 
treatment.
Ifyleran has been shown to damage the chromosomes and 
especially the mitotic apparatus (Koller, 1969)* The damage 
to the mitotic apparatus is probably of a general nature since 
the effects of Myleran found in the present study are not 
confined to a single phase.
The Effect of Myleran on the Incidence of Mitotic 
Abnormality in Regenerating Liver.
Abnormalities in all phases of mitosis were found 
in both control and Myleran-treated rats. The large number of 
abnormal figures in controls is unusual. Whereas most previous 
studies have considered only anaphase and telophase abnormal­
ities, since abnormalities in these phases are easier to 
recognise and less equivocal, fewer abnormal phases were found 
after partial hepatectomy; Fabrikant (196?) gives a figure of 
10-15^ , while Albert (l958) and Horst & Rudnicki (1962)
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give between 2-79^  abnormal mitotic figures. It should be 
emphasised that recognition of a mitotic cell as abnormal is 
necessarily highly subjective, even though the criteria of 
abnormality (5#10) were strictly adhered to in the identi­
fication of abnormal cells. Dimethyl sulphoxide, used In both 
control and experimental groups is unlikely to have given 
chromosome abnormalities. On injection of 0.4 ml intraven­
ously into rats it was shown to damage hepatocytes (Shilkin, 
Papadimitriou & Walters, I966) but chromosomal damage was 
not noted.
Slight increases in the ^  of abnormal prophase and 
metaphase cells were seen in the period up to 24hr. after 
operation and Myleran injection, but no general increase in 
abnormal anaphase or telophase figures was found. A high ^  of 
abnormal anaphase and telophase cells was found in the mitoses 
of Myleran-treated rats at 24hr. Interference with mechanisms 
controlling the orderly process of mitosis, could explain the 
shortened length of the mitotic phases and the higher incidence 
of abnormality.
Myleran has previously been found to be mutagenic 
in barley, wheat and Drosophila (Lundquist et al. 1968;
Mackey, 1968; Svetlov & Vorsakova, I968).
• IJO —
The Effect of Myleran on Mitotic Index during 
Liver Regeneration.
In adult liver only .01^ of the parenchymal cells 
are generally in mitosis (Bucher, 1963). Thus the onset of a 
large number of mitoses is a very sensitive indication of 
regeneration. Mitotic indices can be a misleading guide to 
regeneration, since procedures such as laparotomy or anaesthesia 
cause a 10-20 fold increase in the mitotic index in liver with 
no accompanying increase in liver mass (Servis & Kennedy, 1963). 
Further disadvantages of the mitotic index as an index of 
growth are its subjectivity, sampling errors and the short length 
of the mitotic peak.
The high values of mitotic index for l^leran-treated 
rats have a large standard deviation making these values 
uncertain, the values at low mitotic index are less variable 
and significantly depressed compared with controls.
The Effect of Myleran on the Lengths of the Cell 
Cycle Phases of Regenerating Liver Cells.
A curve of ^  labelled mitoses was used to find the 
lengths of the four cell cycle phases in the present study as 
it is the only method generally applicable in vivo. Other 
methods using double or continuous labelling, and the use of 
drugs to *block* cells at a particular point in the cell cycle.
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are often better applicable to cells in cnltnre, or are 
limited to the determination of the length of one phase#
Three methods are available to analyse curves of 
labelled mitoses. The first is direct measurement from the 
curve. Secondly, a simulated curve may be constructed by 
iteration using a Monte Carlo programme until simulated and 
experimental curves are consistent (Barrett, 1966). This 
method vas not used as it is cumbersome and has been super­
seded by the method of Okumura, Onozawa, Morita & Matsuzawa 
(1973)» using an improvement of Barrett's equation for a curve 
of labelled mitoses. Cell cycle parameters may be estimated 
from the straight lines found by plotting ^  labelled mitoses 
on probit paper. This method was used in the present work 
as it is simple and gives results in good agreement with those 
found using the Monte Carlo programme. Measurements made 
directly from the curves of 9® labelled mitoses yielded comparable 
results. Values for the lengths of and M phases ^ d  T for 
control rats were obtained by direct measurement from the curve 
of ^0 labelled mitoses; these parameters were unobtainable from 
the plots of labelled mitoses on probit paper for either 
control or Myleran-treated rats.
A level of 85^ labelled mitoses reached in the case of 
the Myleran-treated rats, compares with the 89^ level found for 
controls (Fig. 19)# The curves of labelled mitoses did not 
reach lOOÿ labelling, partly because the cells were not
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synchronous when the 'pulse-lahel* of thymidine was
injected. Lack of synchrony is due to variation in length of
the cell cycle phases. Hepatocytes are not a homogenous
population and have different cell cycle times in different
parts of the liver lohule (Rahes et al. 1972), The length
of the S phase estimated for îfyleran-treated rats was found
to have a larger standard deviation (c5), or range of values,
than that found for controls (Table lO). The standard deviation
for the Grt phase (C^ - ), was less in Ifyleran-treated rats
2
than the control value. The coefficient of variation relates 
standard deviation to the length of the phase under consideration 
and corresponds to the degree of asynchrony of the cells in the 
phase. The coefficient of variation for the S phase was 
slightly greater for Myleran-treated rats, though for the Gg 
phase the coefficient of variation after Ifyleran treatment 
was half that of the control value. A decrease in synchrony 
for cells in the S phase but an increase in synchrony for cells 
in the G^ phase was thus an outcome of Myleran treatment.
Another cause for the lower (<1005©) proportion 
of labelled mitoses is that partial hepatectomy induces a 
flow of parenchymal cells from a polyploid G^ population 
directly into division. These cells do not pass through S and 
consequently do not take up labelled thymidine; this occurs 
especially amongst parenchymal cells around the central vein 
of the liver lobule (Srauer, 19^ 3i Fabrikant, 1964). The 
effect of Myleran on this population was not studied in the
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present work. An additional reason for the mitotic 
labelling curves not reaching 100^ may be that a proportion 
of labelled cells were taken as unlabelled (false negatives), 
due to self—absorption of the ^  particles or latent image 
fading. The lowered 6^— thymidine incorporation found 
after Myleran injection may have increased the proportion 
of false negatives compared with controls, and may account 
for the small decrease observed between the labelling maxima 
found for control and Ifyleran—treated rats.
That the S phase was only slightly increased in 
duration in the lÿleran-treated rats was predictable from the 
similar pattern of labelled thymidine incorporation (Fig. 3) 
for control and Ifyleran—treated rats. An increased length 
of S phase is consistent with the decreased rate of DNA 
synthesis found after Mylerem injection. The increase in 
length of the phase may be related to the effect of Myleran 
on one or more of a number of events occurring in this phase. 
Peterson, Tobey & Anderson (1969) found, in in vitro experiments 
with Chinese hamster ovary cells, evidence for three temporal 
markers subdividing the Gg phase. One marker was represented 
by the end of essential RNA synthesis, another was the 
synthesis of a protein allowing the cell to enter mitosis and 
the third was the synthesis of a protein allowing the cell to 
complete mitosis. The decreased protein synthesis which must 
result from the decreased DNA synthesis found after Myleran 
injection, may delay synthesis of the requisite protein(s)
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allowing liver cells to divide. This delay would result in 
a longer period.
Different times for the duration of the mitotic (m) 
phase of the cell cycle were found depending on the method of 
determination. Metaphase, anaphase and telophase times were 
estimated from the average ^  of these cells determined hourly 
over a 9hr. period; only prophase was estimated graphically 
from the time between the first appearance of labelled prophase 
and metaphase cells. The mitotic time obtained from summation 
of prophase, metaphase, anaphase and telophase, was considered 
to be more reliable than estimation of the M periods from the 
times of ascent of the first mitotic waves on the curves of 
labelled mitoses (Fig. I9). The ascending limbs of the curves 
of °fa labelled mitoses were drawn by eye as curves of best fit. 
Both methods however, show that Myleran shortens the mitotic 
period. The mechanism whereby M phase is shortened is unclear. 
A shortening of the mitotic period has also been found for 
regenerating liver subjected to irradiation before partial 
hepatectomy (Fabrikant, 1968a). The lowered mitotic time 
found in the present work may be a compensatory mechanism 
for the decreased DNA synthesis.
The total cell cycle time (T^ ), may be estimated as 
the interval between corresponding points on successive mitotic 
labelling waves. T  ^was not obtainable, for Myleran-treated 
rats, from the graph of io labelled mitoses (Fig. 19) because
- 135 -
the second wave of labelling was too low to be followed. 
The maxima of DNA. synthesis (Fig. 3), however, are at 
similar times for 1^1 cran-treated rats and controls and it 
may be therefore inferred that is not greatly altered 
after Ifyleran injection.
— 1)6 —
CONCLUSIONS
1# The decrease in DNA. synthesis consequent upon Myleran
injection Is postulated to he due to inhibition of DNA 
polymerase.
2. Inhibition of DNA polymerase would cause an increase
in TTP concentration. TTP has previously been shown to inhibit 
thymidine kinase. Its steady build up might explain the 
decreased activity of 'apparent* thymidine kinase, which was 
measured in vitro, and whose decrease was of the same order of 
magnitude as the decrease in DNA synthesis. The 'apparent' 
enzyme activity was de-inhibited on dilution of the homogenate.
3. Minima are found in proportional DNA-P content of the 
liver in controls and Myleran-treated rats which correspond
to the times of maximal DNA synthesis. The values are suggested 
to be the result of large increases in cell constituents other 
than DNA which take place both before and during the periods 
of rapid DNA synthesis.
4. Myleran has little effect on ENA content.
5. l^leran probably has little effect on fluid balance
in the liver after partial hepatectomy. A slower regenerative 
rate than that found in controls must be due to decreased 
DNA synthesis.
- 137 -
6. Damage to the mitotic apparatus caused by Ifyleran is
thought to be of a general nature since effects are not 
confined to a single mitotic phase.
7# Interference with mechanisms controlling the orderly
process of mitosis could explain the shortened length of the 
mitotic phases and the higher incidence of mitotic abnormality 
found after Myleran injection.
8. Both high and low values of mitotic index are found 
after Myleran treatment; the low values however, have 
associated low deviations and are significantly depressed 
compared with controls,
9. The greatest effect of Ityleran is found when it is 
injected in the phase.
10. Cell cycle times are estimated by direct measurement 
from curves of ^  labelled mitoses and by plotting these curves 
on probability paper. The two methods give comparable results. 
The S phase is almost unchanged in length, while an increase
in synchrony of cells in G^ phase is an outcome of Myleran 
treatment. The G^ phase is increased in length, perhaps 
as a result of the decreased protein synthesis which must result 
from the decreased DNA synthesis found after Mÿleran injection: 
the requisite protein(s) allowing liver cells to divide may be
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synthesised tardily so lengthening the Gg phase. The M phase 
is found to he decreased in length. This may partially 
compensate for decreased DNA. synthesis hy 'speeding up' 
the cell cycle. The total length of the cell cycle is 
probably not greatly altered after Myleran injection.
11. Ifyleran is thought to act at many sites since it 
is capable of binding to DNA, ENA and protein of the liver; 
damages the mitotic apparatus and interacts with lipid in 
regenerating liver ( 3*1*1 ).
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FUTURE WORK
The system of regenerating liver seems suitable 
for the investigation of the mode of action of drugs on 
cells and tissues. Other chemotherapeutic compounds used 
in the treatment of cancer such as chlorambucil could be 
investigated in a similar manner to that in the present 
study.
The effect of Myleran on the precursor nucleotide 
'pool* sizes and on ENA. synthesis, not investigated in the 
present work, would be of interest, A study of the individual 
enzymes involved in the incorporation of thymidine into DNA 
may help to localise the enzyme(s) most affected by Myleran,
It is intended to investigate DNA polymerase activity.
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